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Abstract
Healthy vasculature is critical to sustaining the function of normal tissues in the human
body. Radiation therapy for cancer causes injury of the vasculature of non-cancerous tissues.
These changes have been associated with potentially deadly conditions such as necrosis of
the brain tissue. There are currently no computational methods to study the eﬀects of radiation vascular injury in whole-organ vasculatures because of the large number of vessels
involved. The goal of this work was to test the feasibility of simulating radiation damage to
whole-brain vascular networks and calculate the resulting change in blood flow. To accomplish this, we developed algorithms to create a fractal-like geometry with 17 billion vessels,
simulate the radiation dose to those vessels, and calculate the resulting change in blood flow.
Computational performance metrics were measured for each algorithm individually and as a
complete pipeline to determine the computational feasibility. Using a modular system containing these algorithms, we demonstrated that it is computationally feasible to predict the
eﬀects of radiation on blood flow in whole-organ vasculature. The system required 90 hours
to perform the simulation for 2 million protons incident on an 8.5 billion vessel network using 128 compute nodes. Furthermore, the dose calculations were determined to be the most
time consuming part of this system. The vessel-geometry algorithm and blood-flow algorithm both demonstrated the ability to reach 17 billion vessels. With future improvements,
whole-organ simulations of vascular injury have the potential to elucidate the importance of
vasculature to the development of radiation late eﬀects.

v

1. Introduction
1.1. Context
It is estimated that in 2019 approximately 1.8 million people will be diagnosed with
cancer in the United States [1]. Improvements in cancer treatment have improved the 5year survival rate from 50% in 1975 to 69% in 2019 for the US population [1]. Because
people are living longer after a cancer diagnosis, it is increasing important to consider the
detrimental long-term eﬀects of their treatment [2]. Radiation therapy is a widely-used
treatment modality due to its ability to non-invasively and accurately target a tumor [3].
The long-term side eﬀects of radiation therapy include second cancers [4], fibrosis [5], and
white-matter necrosis [6] to name just a few. Necrosis in the human brain can significantly
impact the quality of life and possibly cause death in up to 25% of patients who receive
heavy ion therapy[6].
Necrosis is defined as a swelling of cells followed by a catastrophic rupturing of the cell
membrane, releasing inflammatory factors into the tissue [7, 8]. These inflammatory factors
can cause other cells to enter necrotic-death pathways, leading to the formation of a large
necrotic region in tissue. Necrosis can be triggered by ischemia, hypoxia, and other eﬀects
that disrupt cellular equilibrium [9]. There are two hypotheses regarding the initiating cause
of necrosis in the brain. The first is the death of glial cells that support the function of
neurons [10]. This causes a cascade of cell death that leads to the formation of a necrotic
lesion. The second hypothesis is radiation-induced vascular injury leads to the formation
of necrosis, involving regions of ischemia, hypoxia, and changes in the blood brain barrier.
[10, 11]. These hypotheses can, in principle, be tested in part by considering the physics
of the delivery of oxygen and nutrient delivery by the vasculature. Hence, simulations of
radiation-induced injury on blood flow could be used to probe the physical determinants of
radiation necrosis.

1

1.2. State of Knowledge
The human brain contains up 9 billion blood vessels in the densest vascular network in
the human body [12, 13]. Many of these blood vessels are capillaries, which are responsible
for transferring oxygen and nutrients to the glial cells and neurons. It has been demonstrated
that accurately modeling the blood flow in the cortex depends on accurately modeling the
blood flow in the capillaries [14]. The average brain capillary has a length of 55 µm and
the smallest radius is 2.5 µm [12]. In a first principles approach to simulating the eﬀects of
vascular injury from radiation on the blood flow in the brain, it is necessary to model each
vessel, the dose it receives, and the flow of blood through it.
The modeling of vascular geometry has progressed during recent decades. One method
is to reconstruct vascular geometry from high resolution imaging techniques [15–18]. These
techniques are typically limited to small volumes and destroy the sample in most cases. Recent advances have enabled researchers to construct realistic geometries using computational
methods. One widely-used computational technique is constrained constructive optimization
(CCO) [19]. CCO uses a stochastic approach to fill the target volume with vasculature, while
optimizing the vascular density, sheer stress, and blood flow [20]. Linninger et al. [21] coupled CCO with a Voronoi mesh technique to computationally create a 27 mm3 segment of
the human brain. This small volume contained only 256,000 vessels but accurately reproduced the morphometric measurements of the brain. Another technique is the application of
fractal methods to create vascular trees [22–24]. These models have seen extensive use in the
modeling of arterial trees for organs [22, 25]. The natural simplicity of a fractal enables an
efficient computation of vascular geometry, however it is limited in it is ability to produce a
realistic, 3-dimensional geometry [26]. The largest vascular geometry previously constructed
was limited to 360,000 vessels [27], 10,000 times fewer than in the human brain.
Radiation transport to small targets, such as the capillaries, necessitates calculating
the interactions of each particle track with each individual vessel. Monte Carlo methods
simulate the deposition of energy in a geometry by using probabilistic methods guided by
2

interaction cross-sections [28]. These techniques have been used to great eﬀect for simulating
the radiation chemistry of DNA damage [29], treatment planning [30, 31], and whole-body
dose reconstructions [32, 33]. Monte Carlo techniques, while accurate, are computationally
expensive, especially as the level of detail increases. This prevents the simulation of large
volumes with many small targets, e.g. the vascular network of a human brain. One way to
reduce the computations is to not transport the individual secondary particles, e.g., delta
rays, that are created by the primary radiation. An alternative is to aggregate the transport
of delta rays using amorphous-track structure models [34–36]. These models replace the
transport of the individual secondary particles with an analytical approximation of the mean
dose deposited by all the delta rays from a track. This reduces the computational complexity
and expense. Track structure models are commonly used to model biological responses, e.g.,
they are using in treatment planning systems for heavy ion therapies [35].
The biological modeling of radiation damage is typically limited to cellular responses
and mechanisms [37]. Using closed form equations, the dose is converted to a cell survival
fraction [37]. The cell survival fraction has been used to model the clinical response of normal
tissues and tumors due to radiotherapy treatments [38, 39]. The study of radiation’s eﬀect
on vasculature using computational methods has been limited. The most comprehensive
work on vascular network changes due to radiation studied rabbit ear vasculature [40, 41].
These studies provided details on the relative change in vessel length, radius, surface area,
and volume versus the dose deposited, but was limited to population averages and assumed
a uniform dose. More recent studies have focused on the eﬀects of radiation on vascular
function and correlate the damage with changes is tissue function [42–45]. All of the previous
studies on the impacts of radiation on vasculature have ignored the eﬀects that changes in
vessel structure and function have on blood flow through an organ.
The simulation of blood flow is a mature field. The most advanced and accurate technique for simulating blood flow through vessels is finite-element modeling. In this approach,
a vascular network is broken into a finite number of small volumes. The Naiver-Stokes equa3

tions are applied to each element, creating a system of partial diﬀerential equations that can
be solved to determine the blood flow [46]. Finite-element models have been used to simulate the blood flow for research on stents [47–49], strokes [50, 51], and aneurysms [52, 53].
Each of these simulations is computationally complex and has been limited in the number
of vessels that can be simulated, i.e., less than 50 vessels [54, 55]. Simplifying the blood flow
theory can increase the maximum number of vessels modeled in a simulation, but this comes
at the cost of reduced physical accuracy [21, 56, 57]. Linninger et al. [21] successfully used
a steady-state approach to simulate the blood flow through 256,000 vessels and quantify the
local tissue oxygenation in a 27 mm3 section of human brain. This is the largest study of
blood flow in individually modeled vessels to date.
To summarize, simulations of vasculature have been limited to small volumes with highlevels of detail or large volumes with less vascular details. However, the radiation delivered
during a therapeutic treatment has the potential to damage blood vessels through out the
human brain. These changes in individual vessels, while small, can collective impact the
blood flow in a significant way. Currently, there are no no proven methods that can construct
a geometric description of, calculate the dose to, or simulate the blood flow through a vascular
network containing 9 billion individual vessels. It is currently unknown if it is feasible to
perform each of these tasks using current high-performance computing resources.
1.3. Objective
The objective of this work was to test the feasibility of simulating radiation damage to
whole-brain vascular networks and calculate the resulting change in blood flow. To accomplish this, we first developed and evaluated an algorithm to create a reproducible vascular
geometry with billions of individual vessels (Chapter 2). Next, we tested the feasibility of
calculating blood-flow rates using a steady-state approach (Chapter 3) and evaluated the
accuracy of the model (Chapter 4). To facilitate the dose calculations, we developed an
analytical formula for stopping powers of heavy ions spanning five orders of magnitude in
kinetic energy (Chapter 5). Finally, we developed a recursive dose algorithm to score the
4

dose from protons to individual blood vessels and tested the feasibility of simulating the
radiation-induced changes in blood flow for whole-brain vasculatures (Chapter 6).

5

2. A Simple Computational Model of the Vasculature of the
Whole Human Brain
2.1. Introduction
The brain controls and coordinates the cognitive and critical motor processes of all vertebrates. In humans it is the second largest internal organ, with a volume of 1.4 L [58].
The human brains contains approximately 200 billion cells, over half of which are neurons
[59]. The neurons play roles in decision making, memory, and eﬀecting action. The cells
that support the neurons can be broadly classified as endothelial cells (of the vasculature)
and glial cells. Glial cells provide necessary support functions to neurons, including neurotransmitter uptake and reprocessing [60] and maintenance of the extracellular environment
[61]. Both neurons and glial cells require energy and oxygen, which are supplied by blood
that is transported through the vasculature. It is estimated that up to 9 billion blood vessels supply the human brain, in the densest vascular network of the human body [12, 62].
Although vasculature has been extensively studied [63–66], its relationship to disease and
injury is not completely understood [67–71]. Vascular injury has been correlated with many
major illnesses and conditions, including Alzheimer’s Disease [72], traumatic brain injury
[73], dementia [74], and radiation-induced complications, such as white-matter necrosis [11]
and fibrosis [5].
The literature is replete with studies on the vasculature of the central nervous system
(CNS) and the gross anatomy of the brain. These are well understood, primarily through
pathologic and morphometric studies, such as those performed by Duvernoy et al. [75] and
Gray and Lewis [76], whose works mapped the positions of larger blood vessels in the brain.
Additionally, we know about the structure of the larger vessels; e.g., arteries have walls
that are thicker and lined with more muscle than veins [76]. High resolution imaging and
histopathology have elucidated physical aspects of microcirculatory anatomy, e.g., the density of the vascular network [12, 13, 62, 77, 78]. An extensive literature describes the func-
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tions of vasculature in normal tissues [79–82] and damaged states [83–87]. Most knowledge
concerning vasculature comes directly from observational studies and experiments.
Relatively less attention has been paid in the literature to computationally modeling
vascular geometry. Much progress has been made in recent decades toward creating models
of vessels and small vascular networks; we briefly review several examples here. One method
is to extract vascular geometries from high-resolution images. Imaging capillaries requires
a technique with a spatial resolution greater than their diameter (i.e., 4 µm ) [17]. Such
techniques include confocal and optical microscopy [15, 16], synchrotron radiation microcomputed tomography [17], and knife-edge scanning microscopy [18]. These techniques are
limited to small volumes (<1 cm3 ) due to long data acquisition times. Another method
simulates vascular angiogenesis, where vessels “grow” according to measured or theoretical
distributions of vascular endothelial growth factor [88]. These models are used frequently
in research studies on cancer, vascular injury, and embryonic development [89–91]. The
angiogenesis simulations require modeling of cellular interactions and vascular growth, both
of which are computationally expensive, thus limiting the simulations to small volumes (<2
mm3 ). Another method is constrained constructive optimization (CCO) [19], which fills the
modeled volume with vessels using a stochastic approach which is constrained by geometrical
and physical quantities like vascular density, sheer stress, and blood flow [20]. Due to its
random nature, the method constructs networks that are geometrically similar to those of
the human body [92]. Recently, Linninger et al. [21] coupled CCO with a method to create
mesh-like micro-vascular networks in order to completely model 27 mm3 of the human brain
with a high degree of completeness and realism. Yet another method uses self-symmetric
fractals, which can accurately reproduce the statistical distributions of network properties
[22–24], but are limited in their ability to create a realistic 3-d network [26]. These models
have typically been applied to the arterial tree of an organ [22, 25]. While each of the
aforementioned methods is theoretically capable of creating a whole-organ vasculatures, no
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attempt has been reported to computationally model the vasculature of any whole organ of
a mammal.
The objective of this study was to determine if it is computationally feasible to create a
model of the vasculature of the whole human brain containing 9 billion vessels. Using a simple
fractal-based geometry algorithm and high-performance computing systems, we estimated
the minimum computational requirements to create vasculature with 8 to 17 billion vessels.
In particular, we determined the computation speeds, electronic memory requirements, and
persistent storage requirements.
2.2. Methods
2.2.1. Vascular Model
We developed an algorithm to create arbitrary-sized vasculatures, comprising a 3dimensional (3-d) network containing from just 6 vessels up to 17 billion vessels, i.e. the
number in the human brain. A fractal-based approach was adopted for its algorithmic
simplicity and its inherent applicability across multiple dimensional scales.
The network model comprises two symmetric halves, an arterial tree and a corresponding
venous tree, each with an equal number of vessels. In this model, each successive bifurcation
of vessels is called a generation and occurs at vessel junctions (Figure 2.1). In each tree, a
parent vessel branches into two child vessels that are of smaller diameter than the parent.
The trees grow toward one another, meeting at the midplane. This technique produces a
mirror-symmetric network that begins with one artery and ends with one vein.
The model includes descriptors of each vessel’s geometry and its connections to other
vessels in the network (Figure 2.2). The geometric descriptors include the start and end
locations of a vessel and its inner (lumen) radius. The descriptor of a connection of vessels
includes the identity of each vessel in that connection and the labels for the junctions at both
ends. Junctions in this work refer to the location of abutments between two vessels (i.e.,
where a capillary from the venous tree contents to one in the arterial tree), bifurcation points
(i.e., where three vessels connect), and the start and end points of the vascular network.
8

Figure 2.1. An illustrative example of a 2-dimensional vascular network generated with
fractal methods. The arterial tree is represented with solid lines, while the venous tree is
represented with dashed lines. The direction of construction in each tree proceeds from the
largest to smallest vessel.
2.2.2. Algorithm to Construct Simple Vascular Networks
2.2.2.1. Algorithm Overview
The first step in creating a 2-d or 3-d vascular network was to calculate the start and end
locations of the network (Figure 2.3a). The start location corresponds to the source of the
arterial tree and the end location to the sink of the venous tree. Next, the first vessel in each
tree was constructed (Figure 2.3b), which was followed by bifurcations. For each successive
generation, we reduced the vessel radius, bifurcation angle, and length using scaling factors
selected to avoid geometric overlapping of vessels. Then child vessels were constructed for
each parent (Figure 2.3c-f). This branching process occurs for NG generations of vessels
in both trees, i.e., until the two trees meet at the midplane. After all generations were
constructed (in both trees), the vessel descriptors were updated with information on vessel
connections at the midplane. We constructed the arterial and venous vessels in the trees
9

Figure 2.2. An illustration of the types of descriptors used in the geometric model of the
arterial tree. Specifically, this highlights the vessels that are connected to a Child vessel
(Vessel 1), including its parent. In this example, the two vessels at the bottom are not
associated with the Child but are still part of the same network. The network start location
is used to specify boundary conditions for blood flow calculations.
simultaneously for two reasons. First, because of the mirror symmetry, most of the geometric
computations were shared, which reduced the calculation time required. Second, doing so
guaranteed that the trees met at the midplane, thus simplifying their connections to one
another. The number of vessels in a completed network is
NV = 2NG +1 − 2

(2.1)

where NG is the number of generations in the network. 3-d networks were created by alternating whether the bifurcations occurred in the x-z or y-z planes. Figure 2.4 shows a
flowchart of key aspects of network construction.
10

Figure 2.3. An overview of the sequence of steps in constructing the vascular network. Panel
(a) depicts the network start and end points, (b) the first generation of vessels in the network,
(c) the second generation of vessels, (d) the first set of vessels in the third generation, (e) the
second set of vessels in the third generation, and (f) midplane connections and the completed
network. Solid lines represent previously constructed vessels. Dotted lines represent newly
constructed vessels that are not yet fully connected to the network.
11

Table 2.1. The user defined parameters that govern the construction of 2-d
and 3-d vascular network models.
Value
Parameter (units)
2-d
3-d
Number of Generations
3 ≤ NG ≤ 32
Geometry Dimensions
2
3
Radius of the Smallest Radius (µm) 2.5
2.5
Radius Scaling Factor
2-1/3 2-1/3
Length of the Smallest Vessel (µm)
55
55
Length Scaling Factor
0.8
0.8
Initial Bifurcation Angle (°)
70
33.31
Bifurcation Scaling Factor
0.6
0.88

Source
This work
This work
Linninger et al.[21]
Adam [93]
Lauwers et al. [12]
This work
Adam [93]
This work

To construct a new pair of child vessels at a bifurcation, we used the end point of the
parent vessel as the starting point of each child vessel (Figure 2.2). We calculated end points
for each child vessel based on the bifurcation angle and vessel length of that generation. Next,
the connection descriptors were computed. Each new record of a child vessel was assigned
its parent’s end bifurcation identifier and a new, unique identifier for the new child’s end
junction. Figure 2.4 shows a flowchart of the algorithm for implementation on a single
computer.
Table 2.1 lists the parameters that govern the geometry of the vessel network. These
user-supplied parameters included the number of vessel generations, selection of 2-d or 3-d
network geometry, radius of the smallest vessel, length of the smallest vessel, the bifurcation
angle of the first generation, and scaling constants describing how these quantities change
with each successive vessel generation. We selected the initial bifurcation angle for 3-d
networks from Adam [93]. For 2-d networks, the initial bifurcation angle was selected to
avoid overlap of the vessels in order to enhance visual clarity. The bifurcation-scaling factor
ratio and length-scaling factor were selected to eliminate geometric overlapping of vessels in
2-d and 3-d networks.
After constructing the geometric description of the vascular network, the data was saved
to persistent storage. This enabled the data to be used in other applications, such as programs that calculate blood flow and radiation transport.
12

Figure 2.4. Flowchart of the algorithm to create a vessel network when implemented to run
on a single computer.
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2.2.2.2. Distributed Parallel Algorithm to Construct Simple Vascular Networks
Whole-organ vascular networks occupy vastly more electronic memory than is available
on a typical contemporary compute node. To overcome this obstacle, we implemented a
divide-and-conquer approach. This enabled parallelization across multiple compute nodes,
which facilitated the construction of networks with more than 26 generations, corresponding
to approximately 135 million vessels.
In the first stage of the parallel algorithm, each compute node constructed the root trees
(Figure 2.5a) of the arterial and venous networks. The root trees were constructed following
the methods in Section 2.2.2.1, however construction was stopped after a specified number
of generations (Nroot ). Specifically, the number of vessels in the final generation of the root
trees was equal to the number of compute nodes being used (Nn ). The number of generations
in a root tree (Figure 2.5a) is
Nroot = log2 (Nn ) + 1 .

(2.2)

The second stage connected the root trees (Figure 2.5a) by constructing sub-networks
(Figure 2.5c). To accomplish this, each compute node was assigned a pair of vessels to
connect (Figure 2.5b) and then used the algorithm discussed in Section 2.2.2.1 to connect
the assigned vessels. Each sub-network (Figure 2.5c) was constructed independently on a
single compute node.
2.2.2.3. Implementation of the Algorithm
Two versions of the vascular construction algorithm were implemented: one for a single
compute node and another for a distributed-parallel computing system. We implemented
the algorithms in the C++ language and compiled them with commercial tools (Intel C++
Compiler 2018, Intel Corporation, Santa Clara, CA, United States). The algorithms were
designed with shared-memory parallelism using OpenMP [94] and distributed memory par-
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Figure 2.5. Illustration of the basic scheme for the division of work in the distributedparallel version of the vascular construction algorithm. This example network has four
generations and was created by four compute nodes. Panel (a) shows the root networks
that are constructed on all the compute nodes. In panel (b) the vessels assigned to each
compute node are shown, while the rest of the root trees are written to persistent storage.
In panel (c), each line style represents the sub-network constructed on each compute node.
The complete network, as it was described in persistent storage, is shown in panel (d).
allelism using the Message Passing Interface (MPI) [95]. We used the implementations of
these parallel constructs provided with the commercial tools.
Persistent storage operations were handled with the parallel Hierarchical Data Format
version 5 (HDF5) library [96]. A single file stored all the data for the vascular network. In
15

the single-node version of the algorithm, all output (I/O) was performed after the entire
network was constructed. In the parallel algorithm, the I/O occured twice. First, the head
node stored the root trees (Figure 2.5a) prior to beginning construction of its assigned subnetwork. Second, following the construction of all the sub-networks all the compute nodes
simultaneously stored the sub-networks (Figure 2.5c) to the same file using the collective
facilities of HDF5. This process was tuned following the techniques of Howison et al. [97] to
maximize performance.
The vessel descriptors were stored in memory using C++ classes. Signed 64-bit integers
stored the vessel and junction identifiers. 64-bit floating point variables limited the impact
of rounding and truncation errors associated with the large dynamic range of the vessel
dimensions, i.e., from micrometers to centimeters. The vessel classes were stored in an
array-based heap to leverage the constant lookup time while resident in electronic memory.
One instance of the vessel class requires only 136 bytes of memory. This corresponds to a
total of 17 GB for a 135 million vessel network, which is available on most contemporary
computers and individual compute nodes of clusters in research settings.
2.2.3. Feasibility Testing
2.2.3.1. Test Environment
We performed the feasibility tests on the SuperMIC cluster at Louisiana State University’s
High-Performance Computing Center. This cluster comprises 360 nodes, each with two 10core processors (2.8 GHz Xeon Ivy Bridge-EP E5-2680, Intel Corporation, Santa Clara, CA,
United States) and 64 GB of shared electronic memory. The cluster is networked with an
InfiniBand Interconnect [98]. A parallel file system consisting of 840 TB of Lustre disks
[99] provided persistent storage, enabling up to 16 compute nodes to operate on the file
simultaneously.

16

2.2.3.2. Computation Speed and Scalability
To determine the computational speed and scalability of the algorithm, we created vessel
networks ranging in size from 14 vessels to 17 billion vessels (3 to 33 generations). The
number of compute nodes (Nn ) used to create a network with NG generations was determined
by
Nn =




1

NG ≤ 26



2(NG −26)

NG ≥ 27

.

(2.3)

Recall that the divide-and-conquer approach was used to meet the sizable memory requirements of large vascular networks (e.g., NG >26). For each of the networks constructed,
recorded the I/O time, vessel network construction time, and the total elapsed wall-clock
time. These measurements were repeated five times in order to characterize variations in the
execution times. We normalized all times to core-hours to reduce dependence on number of
compute nodes to complete the calculations in this study.
To assess the algorithm’s scalability, we calculated the speedup factor (S), or

S=

T1
Tn

(2.4)

where T1 is the time it takes a single compute node, and Tn is the time it takes n compute
nodes to complete the same task. The task was to create a 26-generation vessel network.
This size was selected because it was the largest that could fit in the electronic memory of
a single compute node. We recorded the times for 1, 2, 4, 8, 16, 32, 64, and 128 compute
nodes to create the 26-generation vessel network.
2.2.3.3. Requirements on Electronic Memory and Persistent Storage
To quantify the amount of electronic memory required by the algorithm, we profiled
the application while constructing vascular networks with N G equal to 1, 13, 19, 26, 27,
29, 31, and 33 generations using an open-source memory profiling tool (Valgrind Massif
17

Table 2.2. The number of vessels (NV ) in a network for select number of
generations (NG ). The third column (Nn ) shows the number of compute nodes
required to construct a network of size (NV ) and (NG ).
NG
3
9
17
20
21
26
27
28
29
30
31
32
33

NV
14
1,022
262,142
2,097,150
4,194,302
134,217,726
268,435,454
536,870,910
1,073,741,822
2,147,483,646
4,294,967,294
8,589,934,588
17,179,869,176

Nn Comment
1 Smallest Network
1
1 Approximate Largest Previously Reported [21]
1
1 Approximate Mouse Brain [102]
1 Largest on Single Compute Node
2
4
8
16
32
64 Approximate Human Brain [12]
128 Approximate Human Body[58]

[100]). These networks sizes were selected because they span the current operational range
of our algorithm. We recorded the average and peak amounts of memory usage. For networks
requiring more than one compute node (N G ≥ 27 generations), we recorded the peak memory
requirement and average memory requirement per node.
Persistent storage requirements of the complete vessel network were measured with operating system utilities. For vessel networks with 3 ≤ NG ≤ 32, the resulting uncompressed
and compressed HDF5 file sizes were recorded. Compression was performed post-hoc using
the GZIP algorithm [101].
2.3. Results
2.3.1. Computation Speed and Scalability
Figure 2.6 plots the total time to construct and store vessel networks as a function of
network size (Equation 2.1), revealing that a network with 8.5 billion vessels (approximately
the number in the human brain) was created in 425 core-hours, corresponding to only 22
minutes of wall-clock time. The algorithm constructed a network of 17 billion vessels, i.e.,
doubling the number of vessels in the human brain, in 48 wall-clock minutes. This demon18

Figure 2.6. The time (T ) versus the number of vessels NV created by the algorithm. The
error bars represent the maxima and minima of the 5 trials run for each value. The data
labels specify the number of compute nodes (Nn ) used to create the network. Points without
a label were run on a single compute node. For context, the vertical lines represent estimates
of the numbers of vessels in the human [12] and mouse [102] brains.
strates that our algorithm is capable of constructing network with the number of vessels for
any organ in small animals and humans, and is potentially capable of modeling the 20 billion
vessels contained in the whole human body [58]. Our algorithm created a whole-brain vascular network of a rodent (approximately 3 million vessels [102]) in less than 15 milliseconds
using a single compute node.
Figure 2.7 plots the relative portion of time spent on network construction. I/O time
becomes more important as the network size increases. In the smallest networks, most of
the execution time is spent performing the network construction. In the largest network, the
I/O operations comprise on average 99% of the compute time. Deviation from monotonic
behavior was caused by contention on the I/O servers due to competition from unrelated
compute jobs on the shared resources of the cluster.
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Figure 2.7. The relative fraction of time spent performing network construction (fc ) versus
the number of generations in the network (NG ). In small networks (NG ≤ 16), the vascular
construction algorithm dominated the total computation time. For larger networks, the I/O
(writing to disk) predominated.
We performed scalability measurements on our algorithm by varying the number of compute nodes used to construct a 26-generation network. Figure 2.8 plots the overall speedup,
as well as the speedup of construction and I/O operations individually. This plot reveals
nearly-perfect scalability of the vessel network construction algorithm. Additionally, it highlights how I/O operations limit the scalability and speed of the algorithm, in its current
form.
2.3.2. Requirements of Electronic Memory and Persistent Storage
Profiling confirmed a linear scaling of the electronic memory required as a function of
the number of vessels (Figure 2.9). The average memory required per node was constant
for networks that utilized more than one compute node. The peak memory usage always
occurred during the I/O operations; this was caused by the conversion from data structures
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Figure 2.8. Speedup (S) versus the number of compute nodes (Nn ). The construction
algorithm shows strong scalability. I/O operations demonstrated minimal scalability, which
limited the overall speedup.
in electronic memory to persistent storage. This conversion process is slightly diﬀerent in
the non-parallel and parallel versions of the algorithm, as evidenced by the slight diﬀerence
in the peak memory used between generations 26 and 27 (Figure 2.9).
The persistent-storage file size increased linearly with the number of vessels in the network (Figure 2.10), as expected. For the largest network size (17 billion vessels), lossless
compression reduced the file size from 1.6 TB to 182 GB. On average, output file sizes were
compressed by a factor of approximately 8.
2.4. Discussion
In this study, we used fractal-based geometry to construct, for the first time, a simple
vascular network containing 17 billion fully-connected vessels. We evaluated the algorithm’s
computational speed, scalability, electronic memory requirements, and persistent-storage
requirements using high-performance computing hardware. The major finding of this work
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Figure 2.9. Memory (M ) per node versus number of vessels (NV ). Squares represent maximum memory use, while circles represent the average use during the run. The solid line
represents the transition from the single node algorithm to the distributed parallel algorithm.
The data labels specify the number of compute nodes (Nn ) used to create the network. For
context, the vertical dashed lines represent the estimates for the numbers of vessels vessels
in the human [12] and mouse [102] brains from the literature.
is that it is computationally feasible to construct and store whole-organ vascular networks.
Additionally, we found that the algorithm is fast, scales strongly, and is easily accommodated
by contemporary computers.
The implication of this work is that modeling the vasculature of whole organs may open
new lines of inquiry that were previously thought impossible. For example, modeling of
whole tissue perfusion at the capillary level may find applications in research on drug transportation, circulating tumor cells, and vascular injury. Additionally, it could simplify the
implementation of blood flow algorithms by eliminating complex boundary conditions at
the edges of simulation domains [21, 46]. That said, much additional research and development will be needed to achieve the full potential of this approach. For instance the relative
simplicity of our fractal geometry could be enhanced or replaced with more anatomically22

Figure 2.10. Output file size (D) versus number of vessels (NV ). The circles show the
uncompressed size, while the squares show the size when compressed. The tail for small
networks (NV < 256) is due to a fixed header size in our HDF file. For context, the vertical
dashed lines represent the literature estimates of the number of vessels in the human (Lauwers
et al. 2008) and mouse (David Mayerich, Kwon, and Choe 2008) brains.
realistic geometry. The divide-and-conquer technique could be coupled with more advanced
algorithms, such as constrained constructive optimization [103], improving the geometric
realism of the vasculature. More broadly, the geometric model and algorithm proposed in
this work provides a simple, scalable geometry that can be used to study the performance of
blood flow simulations, vascular visualization algorithms, and other computational research
applications.
The capabilities of computational models may be broadly characterized according to the
number of vessels in the network, geometric realism, and algorithmic qualities. In previous
studies, the largest achieved network sizes were less than 300,000 vessels [21, 104, 105]. The
capacity of our model, in its current form, was 17 billion vessels, or approximately 56,000
times greater than the largest previously-reported network size. Most studies in the literature
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sought to achieve high geometric accuracy of the constructed vascular networks. These used
various techniques, including image segmentation [55, 104, 105], constrained constructive optimization [16, 103], global constructive optimization [106], and self-symmetric fractals [25].
The goal of these algorithms was to provide realistic geometries for simulations, typically of
blood flow. In contradistinction, the goal of this study was to determine the largest achievable network size. We selected a fractal-based approach because it allowed us to probe the
hitherto uncharted computational aspects of whole-organ and whole-organism vasculatures,
e.g., feasibility, scalability, and minimum requirements to create large vascular networks.
Of the previous literature available on computational vascular network modeling, only one
work [106] discussed the computation time required by the algorithm, and it reported the
times to construct only two comparatively small networks. Our study reported performance
information for 30 diﬀerent network sizes (14 ≤ NV ≤ 17 × 109 ), yielding the first set of data
on scalability. In addition, our study characterized the benefits of parallel computing and
the divide-and-conquer approach.
The major strength of this work is its use of generally-applicable methods and widelyavailable computational tools and hardware, which facilitates replication and future extensions. Additionally, the algorithm creates a reproducible and non-stochastic geometry that
is potentially well suited to benchmark problems of relevance to computer-science aspects of
vascular modeling. Benchmark problems will be needed in the future, e.g., when comparing
the performance of algorithms to predict blood flow. Using a benchmark geometry across
research studies would facilitate meaningful comparisons. Another strength of this work
is its focus on the computational performance of the vessel construction algorithm, which
may inform future work to develop more realistic, whole-organ vasculatures. Any algorithms
with increased geometric realism will require more computational operations to create the
same number of vessels, thus requiring more computer resources. Therefore, our model provides estimates of the minimum computational requirements, which may inform the design
of future studies in this area.
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This work has several limitations, most notably, the modest anatomical realism of the
vessel geometry. For example, we assumed a 1:1 ratio of arteries to veins in our network.
This ratio is approximately 3:1 in normal human brain tissue [75]. Furthermore, we used
a symmetric fractal network whereas real vascular networks are partly stochastic in nature.
These are not serious limitations, however, because we believe the divide-and-conquer strategy could be adapted to stochastic methods, such as constrained constructive optimization
[103], in the future. Another limitation of this and previous studies is that the number of
blood vessels in the human brain is poorly known, which makes it difficult to know, with confidence, if the algorithm can indeed model the number of vessels in the brain. Our estimate
of 8.5 billion vessels is in the range 3 to 9 billion vessels estimated from the sparse literature
[12, 13, 58, 76]. This is not a serious limitation because the proposed algorithm was able to
create a vascular network with 17 billion vessels, or approximately double the best estimate
of the number of vessels in the brain. Additionally, the findings on scalability suggest that,
with additional computational resources, which already exist at other institutions, the algorithm could construct even larger vascular networks. Finally, one minor limitation is that we
did not calculate vessel wall thickness in this study. Analytical methods of calculating the
wall thickness are available in the literature Avolio [107]. We implemented these methods in
a companion study with negligible increase in execution time (Chapter 6).
Further investigations are currently underway in our laboratory to demonstrate the feasibility of blood flow simulations in whole-organ vascular networks, using the vascular model
from this work. Additionally, the geometric model is being used to benchmark an algorithm
that simulates radiation dose to vascular networks in whole organs. With the ability to create
geometries with billions of vessels, more detailed studies involving individual microvasculature will be possible.
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3. Feasibility of Calculating the Steady-State Blood Flow Rate
Through the Vasculature of the Entire Human Body
3.1. Introduction
All mammalian life depends on a circulatory system to transport oxygen and nutrients
to organs such as the central nervous system (CNS), liver, and skin. The circulatory system
includes the heart, lungs, arteries, capillaries, and veins [76]. To ensure tissues receive adequate oxygen and nutrients, the CNS and local cellular environments monitor and modulate
blood flow rates throughout the circulatory system [108, 109]. Blood flow may be altered by
disease processes [110], internal and external environmental conditions [111, 112], and stress
and injury [113, 114]. In the United States, cardiovascular and cerebrovascular diseases resulted in approximately 775,000 deaths in 2015 [115] and are expected to cost $1 trillion per
year by 2030 [116].
A great deal is known about the physics of blood flow. The canonical Naiver-Stokes
Equations, derived from Newton’s equations of motion, describe the time-dependent changes
in fluid flow. To solve these equations computationally, the vascular geometry may be broken
into a finite element mesh resulting in a system of partial diﬀerential equations [117], which
is a well understood and widely used technique. Researchers have used this technique to
simulate strokes [50, 51] and stent safety and eﬀectiveness [49, 118] to a high degree of
detail. While it is theoretically possible to solve the three-dimensional (3-D) Naiver-Stokes
equations for all the vessels in the human body, simulations using these techniques are
typically limited to less than 50 vessels [54, 55].
The Naiver-Stokes Equations can be simplified using a variety of assumptions that reduce
the dimensionality, enabling the simulation of larger vascular networks. One popular choice
is the one-dimensional (1-D) time-dependent approximation where the blood is transported
axially along the vessel while assuming angular symmetry of the flow in the vessel [46]. This
approach has been used to model the eﬀects of pulsatile flow on blood vessels [57, 119],
large portions of the arterial tree [56, 120–122], and to predict changes in blood flow due
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to diﬀerent physiological conditions [25]. Time-independent, or steady-state, models further
reduce the dimensionality allowing larger vascular networks to be simulated [123]. This is
an attractive approach because it reduces the computational requirements and simplifies
implementation [124, 125]. Biologically, blood flow is steady in the capillaries and veins of
the human vascular network [119, 121]. This approach has been used to simulate blood flow
through the microvasculature of the brain [21] and heart [126] and to determine the relative
viscosity of blood in vessels [127]. Finally, lumped-parameter or compartmental modeling
groups vessels together into compartments and, using a simple parameterisation, models
the transfer of blood between the compartments [27, 46]. This is used extensively in blood
tracer studies to model the distribution of a drug in diﬀerent organs and tissue compartments
[128–130]. With this approach, it is possible to model the blood distribution throughout the
entire human body but it provides no information on individual vessels [131].
Quarteroni et al. [46] provided an excellent review of blood flow modeling techniques
and described approaches for coupling compartment, 1-D, and 3-D Naiver-Stokes models to
simulate whole-body blood flow. To summarize the literature reports, blood flow can be
simulated with high-levels of detail for a few blood vessels or low-levels of detail for entire
organism. Previous studies performed detailed simulations in small numbers of vessels and
then used simplified models to incorporate the influence of other vessels in the organ or
human body. Hitherto, it is currently unknown if computing the blood flow rate through
each and every individual vessel in the human body was feasible.
The goal of this work is to test the feasibility of calculating the blood flow rates through
17 billion individual vessels, i.e., approximately the number in the human body [58]. To
accomplish this task, we calculated the blood flow rates in a network of vessels that was
modeled with fractal geometry. We used a steady-state approach to calculate the blood flow
rates. The network was geometrically partitioned using graph analysis to reduce the amount
of communication necessary for the blood flow rate calculations, increasing the computational
efficiency.
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3.2. Methods
3.2.1. Modeling Steady-State Blood Flow
3.2.1.1. Geometric Model
The vascular geometry used in this study was constructed with a symmetric, fractal approach. Vessels were represented as rigid, cylindrical tubes that were connected at junctions
to form a network. The term junction denotes any location where vessels meet, or the start
and end points of the network, where boundary conditions are applied. The fractal model
was conveniently scalable to billions of vessels and had only two boundary conditions, namely
the pressure at the inlet and the blood flow rate at the outlet. The number of vessels (Nv )
in a network was related to the number of bifurcations or generations, denoted by Ng , by

Nv = 2 2Ng − 1 = 2Ng +1 − 2.

(3.1)

In the model, each parent vessel branches into two child vessels. The smallest vessels in the
network were 2.5 µm in radius and 55 µm in length [12]. Between each generation, the vessel
radius was reduced by 2−1/3 following Murray’s Law for bifurcation [93] and the length was
reduced by 0.8 to reduce vessel overlap for visualization [132]. Figure 3.1 plots an illustrative
example of a 2-dimensional network created using this algorithm. The algorithm used to
construct this network geometry was described previously (Chapter 2) [132]. Each vessel was
modeled with a start location, end location, and inner radius, as well as junction indexes,
and a list of immediately connecting vessels.
3.2.1.2. Fluid Dynamics Model
The Naiver-Stokes Equations are well-established in the field of blood flow simulation.
At a point x = (x1 , x2 , x3 ) in an arbitrary 3-D coordinate system, the time dependent form

28

Figure 3.1. A simple illustrative example of a 2-dimesional vascular network with 6 generations. The solid lines represent the arteries, while the dashed lines represent the veins. The
circles depict junctions in the network.
of the Naiver-Stokes equations are

ρ

x, t)
dvv (x
x, t)
− ∇ · T = ρff (x
dt

(3.2)

and
∇ · v = 0,

(3.3)

x, t) is the fluid velocity at time t, T is the fluid stress tensor,
where ρ is the fluid density, v (x
x, t) represents the net change in fluid volume at time t [46]. Equation 3.3 describes
and f (x
the continuity of the blood flow through the vascular network, primarily that the fluid is
incompressible.
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In this work, we simplified the Naiver-Stokes Equations by assuming the flow to be steady,
laminar, and fully developed. These assumptions were originally proposed by Poiseuille in
1838 to calculate the pressure drop of an incompressible Newtonian fluid through a cylindrical
tube [123]. The solution gives the volumetric blood flow rate (Q) in a vessel of radius r and
length L as
πr4
Q=
(Pin − Pout )
8ηL

(3.4)

= C · ∆P
where η is the blood viscosity, C is the conductance of the vessel, and Pin and Pout are the
pressures at the inlet and outlet of the vessel, respectively [21]. To specify the viscosity, η, of
the blood, we used an empirical model for in-vitro blood viscosity adapted from Pries et al.
[127] for a constant hematocrit of 0.45, or


0.645
η = η0 220 · e−2.6r + 3.2 − 2.44 · e−0.06(2r)

(3.5)

where r is the radius of the vessel in millimeters and the value of η0 was 35 mPa · s [133].
Because blood is an incompressible fluid, the net blood flow rate at each junction must
be zero, or, mathematically,
n
X

Qm = 0

(3.6)

m=0

where n is the total number of vessels at the junction and Qm is the blood flow rate of the
mth vessel at that junction (by convention the sign of Qm is positive if blood is entering the
junction and negative if leaving). Using this constraint and Equation 3.4, we constructed a
system of linear equations that described the net flow rates at each junction to determine
the corresponding fluid pressures. For example, in a network with 6 vessels (Figure 3.2) the

30

system of equations was
P0 = Pin
CA (P0 − P1 ) − CB (P1 − P2 ) − CC (P1 − P3 ) = 0
CB (P1 − P2 ) − CD (P2 − P4 ) = 0

(3.7)

CC (P1 − P3 ) − CE (P3 − P4 ) = 0
CD (P2 − P4 ) + CE (P3 − P4 ) − CF (P4 − P5 ) = 0
CF (P4 − P5 ) = Qout
where Pin in the inlet pressure boundary condition and Qout is the outlet blood flow rate.
We specified one pressure and one flow rate boundary condition to assure the problem is well
defined. These six equations are used to determine the six unknown pressures. This system
was cast in matrix form, or
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In this form, the 2-dimensional matrix describes the conductance values of the vessels that
connect junctions while the pressure vector describes the unknown pressures at each junction
(e.g., Pi ’s) and the other vector specifies the net flow rate at each junction. For brevity, the
2-dimensional matrix will be referred to as the conductance matrix for the remainder of the
manuscript. We solved this system of equations using iterative methods [134] to determine
the pressures. With the pressures calculated at all the junctions in the network, we calculated
the blood flow rate, Q, through each vessel using Equation 3.4.
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Figure 3.2. Illustration of a simple vascular geometry showing the geometric relationship
between the blood vessels and junctions. Junctions are labeled with numbers and vessels
labeled letters.
3.2.2. Algorithms
3.2.2.1. General Overview
We designed a two-step algorithm to calculate blood flow rate in a vascular network
of arbitrary size. The first step partitioned the vascular network’s geometry and created
a computationally-efficient division of data using graph partitioning algorithms (see Section 3.2.2.2). The second step calculated blood flow rates through the vessels using matrix
inversion techniques (see Section 3.2.2.3). Figure 3.3 is a flowchart of this algorithm.
We called the first step Network Preprocessing and the second step Blood Flow Rate
Calculations. We developed separate modules for each step to facilitate validation and
testing. Additionally, this modular design simplifies future extensions by allowing additional
modules to manipulate the vascular data prior to calculating the blood flow.
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Figure 3.3. Flowchart mapping the two major steps and selected sub-tasks of calculating the
blood flow in a vascular network.
3.2.2.2. Preprocessing of the Vessel Network’s Geometry
Limitations on the memory available in a single compute node, as well as matrix solver
requirements motivated the first step of our algorithm. For networks with greater than 67
million vessels, the required amount of memory to describe the vessel network geometry and
the conductance matrix exceeded 64 GB available on a single compute node. Our solution
was to distribute the rows of the conductance matrix across multiple compute nodes. The
matrix solver used in this study stipulated that rows of the conductance matrix be distributed
in contiguous groups among the compute nodes [135], e.g., rows 1 -n on compute node 1,
rows n+1 to 2n on compute node 2, etc. To minimize inter-node communication, the network
geometry was partitioned to reduce the number of compute nodes where a given junction
appeared.
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Figure 3.4. Schematic illustration of the eﬀects of graph partitioning on the network data
distribution. Panel (a) shows the distribution of data among the compute nodes after sequentially and contiguously importing the data. Panel (b) shows the distribution of data
after the graph partitioning and renumbering of junction and vessel indexes. In both panels,
the open circles represent multi-partition junctions where communication is necessary for the
construction of the conductance matrix. The number of multi-partition junctions (NMPJ ) is
significantly reduced in Panel (b), greatly reducing the inter-node communication.
The algorithm constructing the network [132] stored the vascular data by level of bifurcation. If the data was read and distributed among compute between nodes sequentially and
contiguously, it resulted in many junctions referenced on multiple compute nodes, reducing
computational efficiency (See Figure 3.4a). We used a graph partitioning algorithm [136]
to group and sort the vessels to minimize the number of multi-partition junctions (Figure
3.4b). A multi-partition junction is a junction where vessels belonging to multiple partitions
meet (Figure 3.4). In practice, each partition is assigned to a diﬀerent compute node during
the Blood Flow Rate Calculations. Thus, to construct the row in the matrix related to the
multi-partition junction, the conductances of all the vessels must be communicated to the
compute node that contains that row of the matrix. To facilitate this communication, one
of the partitions was selected as the master partition. The master partition was used to
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decide which compute node was responsible for collecting the vessel conductance values and
creating the associated row in the conductance matrix. The lists of immediately connected
vessels and the junction indexes were renumbered for consistency with the new partitions.
The newly partitioned and renumbered data was written to the data file for subsequent
processing by the Blood Flow Rate Calculation algorithm.
3.2.2.3. Blood Flow Rate Calculations
Calculating the blood flow rates in the preprocessed network comprised three components:
constructing the conductance matrix, solving for the blood pressure at each junction, and
calculating the blood flow rate through each individual vessel. To begin, each compute node
was assigned one of the partitions created by the Network Preprocessing application. The
compute node then imported the relevant junction indexes, boundary conditions, and vessel
geometry from the data file.
We calculated the pressures at each junction by constructing the conductance matrix and
solving for the unknown pressures. First, the conductance matrix (Section 3.2.1.2) was constructed in compressed sparse row format. This required the communication of conductance
values for vessels that met at a multi-partition junction. The system of linear equations
was solved using an iterative Krylov method [134]. We applied a boundary condition at the
network inlet of Pin = 133.3 Pa, which is the average blood pressure of the cardiac cycle
[137], and a boundary condition was assigned to the blood flow rate at the outlet using
Qout (NG ) = 2NG −1 · vc · πrc2

(3.9)

where Qout is the outlet boundary condition, NG is the number of generations in the network,
vc is the blood velocity in a capillary, and rc is the radius of a capillary. In our geometric model, the radius of the smallest capillary (rc ) was 2.5 µm [12, 13, 75]. Ivanov et al.
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[138] measured the blood flow velocities in capillaries at approximately 1 mm s−1 , which we
assigned to vc .
With the pressures at each junction computed, the blood flow rates in the individual
vessels were calculated according to the following procedure. First, the pressure for each of
the multi-partition junctions was communicated to all the compute nodes. This resulted in
each compute node having the required pressure values to calculate the blood flow rates for
the vessels in its assigned partition. Then, the blood flow rate of each vessel was calculated
using Equation 3.4. To optimize this procedure for computational speed and efficiency, we
converted the problem into a matrix-vector multiplication operation.
In order to verify the calculations were free of blunders, each compute node calculated
the blood flow rate using the following secondary method. For the specific-case of symmetric vascular networks used in this study and the assumption of steady-state physics, we
calculated the blood flow rate (Q) of each vessel of network according to

Q=

Qout (NG )
2l−1

(3.10)

where l is the generation number of the vessel. This simple procedure allowed us to verify
the calculations for networks with up to 17 billion vessels. Following this verification, the
blood flow rates were written to persistent storage media.
3.2.3. Computational Feasibility Measurements
3.2.3.1. Testing Environment
We measured the performance of the algorithm on the QB2 cluster hosted by the
Louisiana Optical Network Initiative. This shared resource has 504 compute nodes. Each
compute node contains 64 GB of memory and two 10-core processors (2.8 GHz Ivy Bridge-EP
E5-2680 Intel Xeon 64-bit). An Infiniband Interconnect [98] provides internode communication and access to persistent storage, comprising a 2.8-PB parallel file system. The file
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system uses a Lustre architecture [99], enabling up to 16 compute nodes to operate on a
single file simultaneously.
3.2.3.2. Software Environment
We compiled all software developed in this study with a commercial C++ compiler (Intel
C++ Compiler Cluster Edition v18.0, Intel Corporation, Santa Clara, CA, United States).
The applications utilized shared-memory parallelism, distributed-memory parallelism, and
linear algebra routines. The compiler provided an implementation of OpenMP [94] for
shared-memory parallelism, an implementation of the message passing interface (MPI) for
distributed memory communication (Intel MPI v18.0), and the Math Kernel Library (MKL
v18.0) of optimized linear algebra routines.
All input and output (I/O) operations to persistent storage for the applications utilized
the Hierarchical Data Format version 5 (HDF5) library [139]. Our applications used the
parallel I/O capabilities of the HDF5 library and the Lustre file system to increase speed.
We tuned the I/O operations following the suggestions of Howison et al. [97].
Graph partitioning in the Network Preprocessing application utilized a k-way partitioning
algorithm implemented in the parallel METIS library (ParMETIS version 4.0.3) [136, 140].
We used the k-way partitioning routine on an edge graph of our vascular network. The
ParMETIS library was compiled with support for large indexes (64-bit) and double-precision
real (64-bit) values to accommodate networks with up to 2.3 × 1018 vessels.
Matrix solving was completed with the Loose Generalized Minimum Residual algorithm
(LGMRES) [141], a Krylov-based iterative solver. We used the BoomerAMG solver [142]
as a matrix preconditioner to accelerate the convergence of the iterative solution to the
system of equations. Implementations of these algorithms were provided by the Hypre Solver
Library [135, 143]. We compiled the library with support for OpenMP and large (64-bit)
indexes. Table 3.1 list the user-specified parameters and options for the matrix solver and
preconditioner. These parameters were determined through an iterative tuning process.
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Table 3.1. Configuration parameters for
the LGMRES [141] and BoomerAMG [142]
solvers used in this work.
LGMRES Matrix Solver Settings
CoarsenType
10
StrongThreshold
0.25
MeasureType
1
KDim
35
Tol
1 × 10-6
AbsTol
2 × 10-6
MaxIter
150
BoomerAMG Matrix Solver Settings
KeepTranspose
True
MaxLevels
20
MaxIter
1
Tol
0
RAP2
True
InterpType
7
PMaxElmts
6
AggNumLevels
2
AggInterpType
1
AggP12MaxElmts
6
AggPMaxElmts
6
RelaxOrder
1
Cycle 1 NumSweeps
1
Cycle 2 NumSweeps
2
Cycle 3 NumSweeps
2
3.2.3.3. Computation Speed
One of the primary metrics for computational feasibility and utility is execution time.
We measured the execution times to calculate the blood flow rate in networks containing
between 14 vessels and 17 billion vessels (3 and 33 generations, respectively). Each calculation was repeated 5 times to quantify system variation in execution times caused by resource
contention in the cluster of parallel compute nodes. For large vessel networks (i.e. NG > 25
and NV > 67, 000, 000), the volume of data required to describe the network and perform
the calculations exceeded the memory of a single compute node (64 GB). The number of
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compute nodes, Np , used was

Np =




1,

for NG ≤ 25



2(NG −25) ,

for NG > 25 .

(3.11)

The Network Preprocessing application was only required for large networks (NG > 25).
Computational execution times were recorded for the Blood Flow Rate Calculations and
the Network Preprocessing independently. The total time, vessel-network-partitioning time,
vessel-index-renumbering time, junction-renumbering time, and I/O time were recorded for
the Network Preprocessing application. For the Blood Flow Rate Calculations, the time to
complete the I/O operations, conductance matrix construction, conductance matrix solution,
blood flow rate calculation, and total times were recorded. We recorded all times in units of
core-hours.
3.2.3.4. Computational Scalability
Weak and strong scaling are two metrics used to evaluate the scalability of an algorithm
in high-performance computing [144]. Weak scaling characterizes the execution time as the
number of processors increases when the workload per processor is fixed, e.g., as the number
of processors doubles so does the workload. Ideally, as the number of processors increases the
wall-clock execution time remains constant. We measured the weak scaling for both Network
Preprocessing and Blood Flow Rate Calculations. For the Blood Flow Rate Calculations,
the smallest size used was NG = 25 on a single compute node and doubled the number of
vessels and compute nodes up to NG = 33 on 256 compute nodes. Because the Network
Preprocessing was only used for more than one compute node, we started with a problem
size of NG = 26 on 2 compute nodes and scaled the application to NG = 33 on 256 compute
nodes.
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Strong scaling characterizes how adding more processors reduces the computation time
of a fixed size problem. This is typically measured using the speedup factor. Ideally, the
speedup factor is equal to the ratio of the new number of processors to the original number
used for the problem [144]. The strong scaling was determined for Network Preprocessing
and Blood Flow Rate Calculations by constructing a fixed-size vessel network (NG = 25)
and varying the numbers of compute nodes (1 ≤ Np ≤ 256). Strong scaling was quantified
by calculating the speedup factor (S) according to

S=

Tq
q · Tn

(3.12)

where Tq is the time it takes a reference number of processors, q, to complete the calculation
and Tn is the time it takes n processors to perform the same calculation. For the Blood
Flow Rate Calculations, q = 1. The Network Preprocessing codes had a reference number
of processors of q = 2.
3.2.3.5. Memory Requirements
Memory requirements for Network Preprocessing and Blood Flow Rate Calculations were
collected separately using a heap memory profiling tool (Valgrind Massif version 3.13 [100]).
We measured the peak and average memory usage for vessel networks with 3, 13, 19, 25,
26 28, 30, and 33 generations. For network sizes requiring two or more compute nodes, the
memory used per node was recorded.
3.3. Results
3.3.1. Computational Feasibility
After implementation, the algorithm illustrated in Figure 3.3 successfully calculated the
blood flow rates in networks containing up to 17 billion vessels. The blood flow rates calculated using our algorithm (Section 3.2.1.2) matched the results calculated using the validation
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Figure 3.5. Plot of execution time in core-hours (T ) versus the number of vessels in a
network (N V ). The arrows signify the number of compute nodes, (Np ), that performed the
calculations (Np = 1 if omitted). The error bars represent the range of compute times of the
5 timing runs. For context, the dashed lines represent literature estimates for the number of
vessels in the human brain [12] and the mouse brain[102].
method (Equation 3.10). The algorithm completed all computations without errors for all
network sizes tested demonstrating that the computations are feasible.
3.3.2. Computational Speed
We measured the execution times of the Network Preprocessing and Blood Flow Rate
Calculation applications (Figure 3.5). A 17-billion vessel network (i.e., approximately the
number in the human body [58]) required 6.5 wall-clock hours to complete using 256 compute
nodes. A 67-million vessel network (i.e., the maximum size that would fit on a single compute
node and more than a whole mouse brain) took 1.8 wall-clock minutes on a single compute
node. Finally, 4-million vessels (i.e., approximately the number of vessels in a mouse brain
[102]) required only 36 wall-clock seconds, also on a single compute node.
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Figure 3.6. Plots of the relative fraction of time (fc ) spent on each task listed in Figure 3.3
verses the number of generations (NG ) in the network. The data for the Network Preprocessing and Blood Flow Rate Calculations are in a and b, respectively. The fraction of time
is normalized to each application’s total compute time, not the overall algorithm time.
To determine which tasks in the applications were consuming the most amount of time,
we computed the relative fraction of time spent performing each task (Figure 3.6). The time
of the Network Preprocessing application was predominated by I/O operations at all vessel
network sizes. This was attributed to our cluster’s high ratio of compute nodes (1-128) to filesystem access points (16), leading to communication bottlenecks. Theoretically, a lower-ratio
architecture will increase the I/O speed. Figure 3.6 also reveals that solving for the pressure
values predominated the execution time in the Blood Flow Rate Calculations, highlighting
the large computational expense of solving a sparse matrix. The fraction of time spent on
solving the system of equations increased dramatically with the number of vessels. This
was partially caused by memory bandwidth limitation inherent to solving sparse matrices.
Additionally, the amount of time spent on inter-node communication required to solve the
system of equations increased with matrix size.
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Figure 3.7. Plots of the wall-clock time (T ) versus the number of processors (Np ) for Network
Preprocessing (a) and Blood Flow Rate Calculations (b). The dashed line represents perfect
scalability. The dark circles represent the overall scalability of Network Preprocessing. Arrows specify the number of vessels in the problem. The labels denote the number of vessels
in the vascular network.
3.3.3. Computational Scalability
To quantify the scalability of the algorithm, we measured both the weak (Figure 3.7)
and strong scaling (Figure 3.8). The weak scaling data shows that both applications scaled
well when the number of processors was below 640 (32 compute nodes). The reasons each
application started performing poorly after 32 compute nodes diﬀered. The Network Preprocessing was limited by the cluster architecture. The application was restricted to 16
I/O channels leading to increasing contention as more processors are added, and thus the
execution time increased. This conclusion is further supported by the strong scaling data
because the computational portions of the algorithm scale extremely well with the number
of processors for the fixed problem size used.
The Blood Flow solving algorithm is limited by the matrix solving algorithm. The lack
of scalability in the matrix solver can be attributed to two primary culprits, increasing interprocess communication with increasing compute nodes and memory use as the problem size
increased. The eﬀects of inter-process communication are evident in the strong scaling data
(Figure 3.8b) because as more processors are utilized the ratio of computation to communi43

Figure 3.8. Plots of the speedup factor (S) versus the number of processors (Np ) for Network
Preprocessing (a) and Blood Flow Rate Calculations (b). The dashed line represents perfect
scalability. The dark circles represent the overall scalability of Network Preprocessing (a) or
Blood Flow Rate Calculations (b).
cation decreases. In the weak scaling measurements (Figure 3.7b), the problem size increased
as the number of processors was increased, reducing the impact of this eﬀect. However, we
see that a majority of the time was still spent on solving the matrix. This is because solving
sparse matrices is a memory bandwidth limited problem. As the problem size grew, more
memory bandwidth was utilized to calculate the matrix elements on each compute node.
3.3.4. Memory Usage
Figure 3.9 plots peak and average memory usage per node for the applications. The
Network Preprocessing application remained well below the 62 GB available on each node.
The Blood Flow Calculation required a peak of about 68 GB which occured during the matrix
solving. This peak is above the available memory per node and could result in performance
degradation due to the use of the hard disk as a virtual memory device.
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Figure 3.9. Plot of memory usage (M ) versus the number of vessels (NV ). The dashed line
marks the maximum available memory on a single compute node (64 GB).
3.4. Discussion
In this study, we developed a two-step algorithm to compute the blood flow rate through a
vascular network corresponding in size to that of the human body. The computational characteristics of the algorithm were measured, including execution time, scalability, and memory
usage, were measured. We successfully demonstrated, for the first time, that whole-body
blood-flow rate calculations are feasible with a contemporary high-performance computing
system. To simulate a network with 17 billion vessels, 6.5 hours of wall-clock time was required using 256 compute nodes (5120 processors). The algorithm scaled modestly as the
number of processors increased, primarily due to limitations of the matrix solver and I/O
operations. In both stages of the algorithm, the average memory consumption per node was
56 GB, i.e. less than the 64 GB available. Finally, the results of this work show that 4
million vessels, the approximated size of a mouse brain [102], executed in only 36 seconds
on a single compute node.
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The primary implication of this study is that new avenues of inquiry are possible that
could elucidate blood-flow problems that were hitherto considered intractable. Several areas
of medical research may find applications for this new capability, including the simulation
and evaluation of injury, healing, disease, and drug delivery. In all of these applications,
knowledge of the blood flow in individual vessels has the potential to improve the accuracy
of physiological simulations, provide new insights, and, ultimately, to improve outcomes for
patients. For example, many drugs are delivered to patients intravenously and the bloodstream transports these drugs throughout the body. A whole-body model of vasculature
could, in theory, enable more accurate localization of the drug within each organ than would
be possible with compartmental modeling for example. Our model may also be used to
validate the findings of compartmental models, as in Hyde et al. [126], but in the much
larger and complete vascular networks of whole organs. Another implication is that a wholebody model, even a simple one, could be used to improve boundary condition estimations
needed for more advanced blood-flow simulation techniques. This would alleviate the need
for cyclic boundary conditions or relax simplifying assumptions currently used. Finally, using a whole-body model of blood flow could facilitate a more complete interpretation of data
from existing diagnostic imaging and nuclear medicine procedures. For example, blood flow
plays a critical role in generating the signal in functional MRI [145]. This imaging procedure
measures the changes in blood flow in the brain and correlates those changes in diﬀerent
regions to brain activity. Being able to model blood flow though the entire brain may enable researchers to draw more robust conclusions from their data by reducing the impact of
confounding changes in blood flow caused by the connected nature of a vascular network.
There are three important characteristics of blood flow models, namely the extent of
the vascular domain simulated, biophysical realism, and computational performance. In the
previous literature, the largest network used in a blood flow simulation was approximately
256,000 vessels, representing a 27 mm3 functional sub-unit of the human brain [21]. Our
model is capable of calculating the blood flow rates through networks containing up to 17
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billion vessels, but with a much simpler geometry. Realism of a blood flow simulation can be
broken down into geometric and physical categories. Our model is comparable in physical
realism to many steady-state models of blood flow [21, 126, 146, 147], which are used for
their simplicity and scalability. 3-D finite element simulations provide superior geometric and
physical realism [27, 56, 104, 119, 122]. One important feature of finite element simulations
is the modeling of the blood’s momentum, enabling accurate modeling of the second-order effects of bifurcations on blood flow rate. Another important characteristic of time-dependent
blood flow rates in the arterial network is cardiac pulsation. Our model intentionally omitted
these features so that we could expand the performance envelope to 17 billion vessels, where
previously reported time-dependent and time-independent models reached less than 300,000
vessels. Similarly, our geometry was less realistic than that modeled in the finite-element
and steady-state studies previously performed. This was done to probe the performance
envelope for billions of vessels. Finally, our work revealed important insights regarding the
computational-performance aspects of blood flow rate calculations. Our literature search
found only two previous studies that provided any details on execution times [104, 119],
and none reported memory requirements. Neither study provided sufficient details to allow
a direct comparison of execution times. One reason for this is that the previous studies
used time-dependent models of the blood flow rate, but neglected to provide the number of
iterations required to solve the system of partial diﬀerential equations. The work performed
by our algorithm is similar to the inner-most loop of a time-dependent simulation, where
a matrix must be constructed and solved. Thus, the timing data reported in our study
could be used to estimate a lower bound of the compute time for whole-body blood flow
simulations using time-dependent models.
To our knowledge, this is the first study to systematically explore the computational
requirements to calculate the blood flow rate through each vessel in the entire human body.
Using the simplified vessel geometry and a steady-state blood flow model, we were able
to provide an estimate of the minimum computational resources needed to perform such
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calculations. This information can be used to inform future research study designs. Another
strength was the use of the Poiseuille equation in representing the blood flow. It minimized
the computational complexity of the problem, making the calculations feasible and results
reproducible. A further strength of this work was the use of realistic lengths and radii for the
vessel lumens in our vascular geometry. This provided a suitable test of the matrix solver’s
ability for resolving dimensions spanning 5 orders of magnitude. Finally, the modular design
of our algorithm allows for the integration of more accurate geometries with the steady-state
blood flow model. In theory, our algorithm could readily accommodate more realistic vessel
geometries, such as those taken from imaging studies [17, 77, 148].
One limitation of this work is that our vessel geometry comprised straight vessels that
were rigid and connected with fixed bifurcation angles. This vessel network geometry is
the only currently known geometry that can be scaled to billions of vessels; a requirement
for charting the performance envelope at the whole-body scale. It was more important to
model the correct number of vessels for the computational feasibility, than it is to model
an accurate geometry for this study. The diﬀerences in the accuracy of this geometry will
be addressed as part of a future research study. Another limitation of this work is that the
blood flow model neglected second-order eﬀects, such as blood momentum, red blood cell
skimming, and vessel compliance [46]. This limitation could be addressed by implementing
a 1-D time dependent blood flow model, which is currently being investigated by our group.
This study has shown that, for the first time, it is computationally feasible to compute
blood flow rates through each vessel in the entire human body with current computing
technology. These results could enable improvements in many fields of research in the life
sciences and provide critical computational insights about the blood flow in whole organisms
and organs.
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4. Accuracy of a Steady-State Model of Blood Flow Through a
Vasculature Containing 126 Vessels
4.1. Introduction
Approximately 775,000 deaths in the United States were caused by cardiovascular and
cerebrovascular diseases during 2015 [115]. It is expected that the treatment of these diseases
will cost over $1 trillion per year by 2030 [116]. The study of vascular diseases is complicated
by the connected nature of the human circulatory system. Because it is a closed system,
localized changes to a vessel can cause non-local changes in blood flow [149, 150]. While
multiple diagnostic techniques exist to measure changes in blood flow, they are limited
to macroscopic domains [151–153] Simulations, in contrast, can predict macroscopic and
microscopic blood flow.
The simulation of fluid dynamics is a mature field, with an extensive body of literature
[154–157]. When simulating blood flow, the gold-standard method is solving the timedependent 3-Dimensional (3-D) Naiver-Stokes Equations [46]. They can model interactions
of blood with vessel walls, red-blood-cell transport, [158], stroke processes [50, 51], and stent
safety and eﬀectiveness [49, 118]. Theoretically, the Naiver-Stokes Equations are applied to
all points in a vascular geometry, resulting in a system of diﬀerential equations. In practice
however, the vascular geometry is descretized using a finite-element mesh [159]. As the size of
the simulation domain grows, the number of elements increases exponentially. This typically
limits the size of the vascular domain that can be simulated to approximately 50 vessels
[54, 55]). By assuming the blood flow is time-independent and laminar, the Naiver-Stokes
Equations may be simplified, which increases the number of vessels that can be simulated.
This technique has been used to model whole hearts [126], a 27 mm3 region of the human
brain [21], and 17 billion vessels (Chapter 3) [160], which approaches the number in the
human body [58]. The latter work focused on computational feasibility of the algorithm
however and the accuracy of the blood-flow calculations was not reported.
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The goal of this work was to quantify the accuracy of the steady-state blood flow model
used to calculate blood flow through 17 billion vessels. We achieved this by comparing the
results of the LSU algorithm of Donahue et al. [160] (Chapter 3) to that of a previouslyvalidated computational-fluid-dynamics (CFD) package. We compared blood flow rates
through networks with 6 to 126 blood vessels. We investigated the model’s ability to simulate the eﬀects of vessel occlusion on blood flow by blocking a single vessel in a 126-vessel
network and comparing the results to those of the commercial package.
4.2. Methods
4.2.1. LSU Steady-State Model for Blood Flow
The LSU model used steady-state fluid dynamics to calculate the blood flow rate in each
vessel using the methods of Donahue et al. [160] (Chapter 3). For the reader’s convenience, we
will summarize the methods here. The governing equation in this model was the Poiseuille’s
equation, or
Q=

πr4
(Pin − Pout )
8ηL

(4.1)

where Q is the blood flow rate, r is the vessel’s radius, L is the vessel’s length, η is the
viscosity of the fluid, and Pin and Pout are the pressures at the input and output of the
vessel, respectively [21]. Blood was assumed to be incompressibile. Therefore, at any point
the blood entering must equal the blood leaving, or
3
X

Qi = 0

(4.2)

i=0

where Qi is the blood flow rate in the ith vessel. To model the eﬀect of red blood cells on
the viscosity of the blood, the LSU Model used an empirical model for in-vitro viscosity for
a constant hematocrit of 0.45, or



0.645
η0.45 = ηabs 220 · e−2.6r + 3.2 − 2.44 · e−0.06(2r)
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(4.3)

where r is the radius of the vessel in mm [127]. The absolute viscosity (ηabs ) of the blood
was taken as 36 mPa s [133].
We calculated the blood flow rate of blood in in two steps. First, Equation 4.1 was applied
to the vessels and Equation 4.2 to the bifurcations. The resulting system of linear equations
was solved using iterative Krylov methods to determine the pressure at each bifurcation [134,
135, 141, 142]. Lastly, we calculated the blood flow rate in each vessel using Equation 4.1.
4.2.2. Computational Fluid Dynamics Model
To test the accuracy of the LSU model we compared its calculated blood flow rates to
those of a commercial computational-fluid-dynamics (CFD) package (Autodesk CFD 2018,
San Rafael, CA, USA). This package was previously validated [161, 162]. The simulated
vessels contained blood and were embedded in human tissue. The physical properties, such
as density, elasticity, and viscosity, of these materials were specified in the material library
provided with the CFD package. Automated tools, included in the CFD package, were
used to create the mesh for each geometry. Table 4.1 lists the settings we used for mesh
generation.
We used the default solver in the CFD package to perform the blood-flow-rate calculations. We required that the solver perform a laminar, steady-state simulation, in accordance
with the assumptions in the LSU-model calculation and Equation 4.1 (see Section 4.2.1).
The Reynolds number [154] was less than 100 for all networks simulated according to calculations performed by the CFD package. Table 4.2 lists the solver parameters we selected for
the CFD package.
4.2.3. Vascular Geometries
4.2.3.1. General Overview
We used two diﬀerent vascular network configurations to evaluate the accuracy of the
LSU blood flow rate model. The first configuration consisted of doubly, (i.e. healthy) net51

Table 4.1. Settings used for mesh generation in
the CFD package. Settings not listed were set to
the default values.
Diagnostics
Minimum Refinement Length
0.0025 mm
Wall Layer
Number of Layers
3
Layer Factor
0.2
Layer gradation
Auto
Advanced
Resolution Factor
0.9
Edge Growth Rate
2
Minimum Points on Edge
3
Points on Longest Edge
10
Volume Growth Rate
2
Surface Growth Rate
2
Enhancement Growth Rate
2
Refinement length
0 or minimum
Fluid Gap Elements
3
works. This allowed us to evaluate the accuracy of the LSU model under simple conditions.
The second configuration was an asymmetric network (i.e., a single vessel occluded). This
allowed testing the accuracy of the LSU model in slightly-more complex geometries. Both
configurations were created in a 2-D plane to simplify visualization of the resulting blood
flow rates.
4.2.3.2. Vascular Network Configurations
The healthy-network configurations comprised between 6 and 126 vessels (2-6 generations
of vessels) in a fractal pattern that was symmetric about the x and y axes (Figure 4.1).
Each vessel in a network was a right cylindrical tube connecting one or two junctions. The
network had a single inlet and a single outlet, which resulted in two boundary conditions.
The smallest vessels were 2.5 µm in radius and 55 µm long, representing nominal capillary
dimensions [12]. Between each generation, the vessel radius was reduced by 2−1/3 following
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Table 4.2. Settings for the CFD solver. Default values were used
for any settings not explicitly listed.
Automatic Convergence Control
Instantaneous Convergence Curve Slope
1 × 10−13
Time-Average Convergence Curve Slope
1 × 10−13
Time-Average Convergence Curve Concavity
1 × 10−13
Field Fluctuations
1 × 10−13
Maximum Iterations
1500
Physics
Compressibility
Incompressible
Turbulence
Laminar
Automatic Mesh Adaptation
Number of Cycles
3
Growth Rate
2
Boundary Layer Growth
1.1
Refinement Limit
0.001
Resolution Factor
0.9
Murray’s Law for bifurcation [93] and the length was reduced by 0.8 to avoid vessel overlap
for visualization [132].
The damaged-network configuration was based upon the 126-vessel network (Figure 4.1)
but with a single vessel occluded. Three diﬀerent network geometries were created, each
with a diﬀerent vessel occluded (Figure 4.2).
4.2.3.3. Creating the Geometric Descriptions
The description of the vascular geometry for the LSU algorithm was constructed with
a fractal-based algorithm (Chapter 2) [132]. Each blood vessels was defined by its start
point, end point, and inner radius. The geometric description also included information
about connections between vessels and bifurcations in the network. Occluded vessels were
represented by setting the radius to zero. The resulting geometric description of the network
was directly imported into the LSU model of blood flow.
The CFD package required that the geometry created by the fractal method be converted
into a discrete 3-D model, where each vessel was represented as a tube. This was done
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Figure 4.1. An example of a 2-D vascular network containing 126 vessels, created with fractal
methods. The left half is considered the arterial tree (solid), while the right side is the venous
tree (dashed).
using a commercial computer-aided design (CAD) package (Inventor 2018, Autodesk, San
Rafael, CA, USA). First, we imported the bifurcation locations and vessel radii from the
LSU model geometry. Next, linearly-tapered vessels were constructed between junctions.
Tapering vessels avoided nonphysical sharp edges at the bifurcations in the CFD model.
The initial radius of each vessel matched the radius of the corresponding generation in the
LSU model while the final radius was the radius of the next generation. The vessels in the
final generation had a constant radius of 2.5 µm. We performed this conversion manually for
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Figure 4.2. Illustration of vessels that were removed from the 126-vessel network (Figure
4.1)to create the 3 diﬀerent damaged-network configurations.
all of the healthy and damaged networks. Occluded vessels were completely removed from
the geometric representation in the CAD model.
4.2.4. Computational Environment
All calculations performed in the study were completed using a personal computer. The
system had a 4-core 4.1 GHz CPU (Core i5-3570K, Intel Corporation, Intel Corporation,
Santa Clara, CA, United States) and 32 GB of memory. The operating system was Windows
10 (Microsoft, Redmond, Washington, United States).
4.2.5. Evaluation of the LSU Blood-Flow Model Accuracy
To quantify the accuracy of the LSU model we compared its calculations of blood flow
rate to that predicted by the CFD package. The LSU model calculated a single value of the
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blood flow rate through each vessel For the CFD package, we recorded the blood flow rate
at the at the middle of each vessel perpendicular to the blood flow.
The boundary condition at the inlet was 133 kPa blood pressure and the outlet boundary
condition was
Q0 (NG ) =

NV + 2
· vc · πrc2
4

(4.4)

where Q0 (NG ) is the blood flow rate at the outlet, NV is the number of vessels in the healthy
network, vc is the blood velocity in a capillary, and rc is the minimum capillary radius (see
Section 4.2.3.2). We assigned vc the value of 1 mm s−1 based of the findings of Ivanov et al.
[138].
Theoretically, blood vessels directly downstream of an occluded vessel have a zero flow
rate. The iterative solvers used in both the LSU model and the CFD package reported
negligible but non-zero values in these vessels that were caused by limitations in machine
precision (e.g., rounding and truncation errors). These non-zero values produced artifacts in
the analysis. To overcome this, we set any blood flow rate less than 1 µm3 s−1 to zero. This
value is is almost 20,000 times less than the theoretical minimum flow rate in the network
(1.9 × 104 µm3 s−1 ).
We compared the blood flow rates calculated by the LSU model and the CFD package
in each vessel. We recorded the the unsigned absolute (|∆|) and relative (|∆r |) diﬀerences
in blood flow reported by the two calculation methods.
4.3. Results
4.3.1. Evaluation of the LSU Blood-Flow Model Accuracy
We compared the blood flow rates predicted by the LSU model and CFD package for
small networks (6-126 vessels). Figure 4.3 plots a representative example of the diﬀerences in
blood flow rates through both healthy and damaged networks calculated by the LSU model.
The CFD package produced similar qualitative results. This shows blood being redistributed
through the network after a vessel had been removed from the 4th generation.
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Figure 4.3. Plot of the blood flow rates in a 6 generation network before (a) and after (b)
removal of a vessel in the 4th generation was removed. The lines represent the vessels, with
the color denoting the flow rate and line weight their relative radii. The black lines represent
vessels that were occluded or have no flow.
Figure 4.4a shows a histogram of the absolute diﬀerences in blood flow rate reported by
the LSU model compared to the CFD package for the healthy networks. This figure shows
that the distribution for all networks considered is centered around 2 × 10−8 mm3 s−1 , with
a maximum error less than 7 × 10−7 mm3 s−1 . Figure 4.4b plots the relative diﬀerence in
blood flow rate between the CFD package and the LSU model for healthy networks. The
relative discrepancy was less than 0.85%. This provides confidence in the LSU model’s
implementation and the accuracy of the calculated steady-state laminar blood flow rates.
Figure 4.5a shows a histogram of the absolute diﬀerences between the LSU model and
the CFD package for the damaged networks. Overall, the LSU model predicted the blood
flow rates with moderate accuracy. The maximum unsigned diﬀerence for all three networks
analyzed was less than 7 × 10−6 mm3 s−1 , while the average signed diﬀerence was 5.3 × 10−7
mm3 s−1 . Figure 4.5b plots a histogram of the relative diﬀerence between the CFD package
and the LSU model for damaged networks. Here, the relative diﬀerence was less than 13%
and the root-mean-square error was 1.9%. This relative accuracy is acceptable based on the
assumptions made in the steady-state model.
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(a)

(b)

Figure 4.4. Histogram of the number of vessels (NV ) versus (a) unsigned absolute (|∆|) and
(b) relative (|∆r |) diﬀerences between the commercial CFD package and the LSU model for
healthy networks. The colors break down the data by the number of generations in each
network.
There are two main reasons for the larger diﬀerences in the damaged networks compared
to the healthy networks. First, the LSU model under-predicted the blood flow rate near
the occluded vessel and the amount of under-prediction decreased with increasing distance
from the occluded vessel. This was caused in part by the tapered vessels in the CFD model,
as opposed to the constant radius of the vessels in the LSU model. This resulted in a
smaller average radius for each vessel than in the LSU model and a decreased flow (see
Equation 4.1). Second, the CFD package included more physical realism than the LSU
model, especially when modeling the eﬀects of junctions and sharp turns on the blood flow
rate. This enabled the CFD model to more accurately handle these eﬀects, making it more
accurate in the redistribution of blood flow. This eﬀect is more pronounced in the damaged
networks than the healthy networks because the vessel occlusion resulted in a sharp bend in
the network geometry. Figure 4.6 illustrates the diﬀerences in blood flow rate compared to
healthy networks.
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(a)

(b)

Figure 4.5. Histogram of the number of vessels (NV ) versus (a) unsigned absolute (|∆|) and
(b) relative (|∆r |) between the commercial CFD package and the LSU model for damaged
networks. The colors break down the data by generation of the removed vessel.

Figure 4.6. Relative diﬀerence ∆r between the LSU model and the CFD package calculations
for the network with a vessel removed in the 4th generation.
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4.4. Discussion
We compared the blood flow rate calculations of the LSU model to those of a previously
validated, commercial CFD package to quantify the accuracy of the LSU model. The major
finding was that the methods calculated blood flow rates with a maximum diﬀerence less
than 1% for symmetric networks, suggesting that the LSU model has comparable accuracy
to the CFD package under the conditions considered. Unlike the CFD package, however, the
LSU model can be used to calculate the blood flow in billions of vessels (i.e., in vasculatures
similar in size to that of the human body). Furthermore, in networks with an occluded
vessel, the LSU model agreed with the CFD package within 13% and an RMS error of 2%.
These results provide a quasi-independent verification of the LSU model, strongly suggesting
that it is free of major systematic errors. Together with previous results (Chapter 3) [160],
these works suggest that the simulation of blood flow through the entire body is not only
computationally feasible, but also sufficiently accurate for present intents and purposes.
The LSU model of blood flow studied in this work could open new avenues of research
in the study of vascular damage. One potential application of this is in the study of the
systemic impact of localized or whole-organ vascular changes, e.g., those caused by trauma,
radiation, or surgery. Many studies on blood flow focus on the pulsatile arterial flow and
truncate their networks before the capillary level. This leads to the application of boundary
conditions at the unconnected ends of the vessel that are based on assumptions regarding
the status of vasculature not modeled. The steady-state flow simulated in the LSU model is
a good approximation of the blood flow through capillaries and veins [119, 121]. The LSU
model could be used to simulate the vascular flow through these, reducing the dependence
on the assumed value of boundary conditions. Another potential application is to investigate
the kinetics of systemic therapies, which are typically transported by the blood. A wholebody model of blood flow could be used to investigate how a drug passes through the various
organs of the body in vessel-by-vessel detail. This could provide statistical approaches to
predict the distribution of a drug throughout a tissue at a microscopic level.
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The accuracy of blood flow simulations is a well studied topic. Sun et al. [163] reported
that their 3-D Navier-Stokes model of blood flow rate diﬀered from experimental measurements by less than 11%, which is comparable to the maximum relative diﬀerence observed in
this work. Another study observed a 1% average diﬀerence between their 3-D Navier-Stokes
model and experimental results [164], which is on the order of the maximum relative diﬀerence seen for the healthy networks in this study. Our work is also comparable to the results
published by Radaelli et al. [165], who compared 7 diﬀerent models of blood flow through
stents, each created by independent research groups. They reported a 5% diﬀerence in the
predicted blood flow rate across all the models tested. This is similar to RMS error observed
between the LSU model and the CFD package (1.9%), lending confidence to the calculations
performed by the LSU model. Many works compare the results blood flow algorithms to
laboratory or clinical measurements [121, 126, 163, 166]. This diﬀers from our computational
approach to validation, making a direct comparison of results difficult.
The primary strength of this work was the use of a commercially available and validated
CFD package. This enabled us to evaluate the accuracy of the LSU model using a systematic
method that was reproducible. This allowed us to investigate the causes of the diﬀerence
between the two models, such as the rounding and truncation errors found in the damaged
networks. An additional strength was the calculation of accuracy in 6 diﬀerent sizes of symmetric networks. This allowed us to quanitify how the error changed as the number of vessels
in the network increased. Another strength of this work was the testing of both symmetric
and asymmetric networks. Vascular networks in the human body are not symmetric in nature. By studying the extreme case of a completely occluded of vessel, we were able to put
an upper bound on the error of asymmetries in the network geometry.
The major limitation of this work was the modest sizes of vasculatures studied. This
limitation was caused by the computational complexity of 3-D finite element solutions to
the Naiver-Stokes equations used in the CFD package. An additional limitation was the
simplified physics implemented in the LSU model, which enables calculations of blood flow
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in 17 billion vessels. In principle, these major limitations can be overcome with additional
research and computing power.
The accuracy of the LSU model was 1% for symmetric (healthy) networks and 13% for
damaged (asymmetric) networks. The LSU model appears adequate to study the distant
eﬀects of network damage in individual vessels. These techniques may open up new fields of
research in systemic therapy and trauma response simulations.
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5. Analytical Model for Ion Stopping Power and Range in the
Therapeutic Energy Interval for Beams of Hydrogen and Heavier Ions
5.1. Introduction
Coulomb force interactions are the primary energy loss mechanisms for hydrogen and
heavier ions penetrating matter. The total stopping power, or an ion’s energy loss per unit
pathlength, comprises energy loss from coulombic interactions of the ion with the atomic
nucleus of the target (nuclear stopping power) and with the target’s atomic electrons (electronic stopping power). The average pathlength traveled by a beam of ions coming to rest is
known as its penetration range. Stopping power and range data are commonly needed for applications such as radiation therapy, radiation protection, ion implantation, and accelerator
physics, as well as in basic sciences such as nuclear and particle physics.
The literature on stopping powers and ranges for hydrogen and heavier ions is vast,
including measurements, theory, evaluations and tabulations, and software algorithms and
programs [168–171]. Electronic stopping powers are typically calculated with either the
Bethe-Bloch equation or empirical functions, depending on the energy regime of the ion.
Nuclear stopping powers are typically calculated using a theoretical approach. Ranges are
commonly calculated numerically using pathlength integration, stopping power data and
the continuous slowing down approximation (CSDA). The Stopping and Ranges of Ions in
Matter (SRIM) by Ziegler and Biersack [172], which provides these and other capabilities,
exemplifies the integration of highly-realistic theories, evaluated data, and radiation transport capabilities. In applications where speed and simplicity are paramount considerations,
analytical calculations of range oﬀer considerable advantages over numerical methods.
Range has long been calculated analytically using a simple power law known as the rangeenergy relationship, or Bragg-Kleeman Rule [173]. This method is accurate for a range of ion
Adapted with permission from: W. Donahue et al., “Analytical model for ion stopping
power and range in the therapeutic energy interval for beams of hydrogen and heavier ions”,
Physics in Medicine and Biology 61, 6570–6584 (2016) ©Institute of Physics and Engineering
in Medicine. Reproduced with permission. All rights reserved
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species (e.g. hydrogen, carbon), ion energies (e.g. 10-200 MeV u-1 ), absorber compositions
(e.g. plastic, water, metal), and thicknesses (e.g. 0.5-110 mm) [174, 175]. The major
limitation of formulas derived from a simple power law relation was their limited energy
interval of applicability, i.e., 10-200 MeV for hydrogen ions in water. Thus, for a projectile in
a target large enough to completely stop it, such as a cancer patient, the simple power law
model for stopping power breaks down in the biologically important interval below 10 MeV.
This energy corresponds to the last 1 mm of a proton’s range in water, which is typically
not a concern in current standard-of-care treatment planning, because the treatment plan is
calculated on a spatial grid similar to the planning image resolution (1 mm). However, there
is considerable interest in performing multi-scale calculations of ion transport e.g., organs
(cm), image voxels (mm), and cells (m). Thus, there is an increasing need for new fast and
simple formulae to calculate range and stopping power values over wider intervals of ion
energy. It was not known if simple analytical equations would meet this need and, if so, the
limits of their applicability.
The aim of this work was to develop a simple, broadly applicable continuous model of
total stopping power which could be analytically integrated to provide a simple formula for
calculating range. More specifically, we sought to develop models with accuracy of 10% in
stopping power and 1 mm in range. To accomplish this, we extended the simple power-law
approach, yielding new analytical formulae for range and stopping power that is applicable to
a wider energy interval. The accuracy was determined by comparison with the best-available
evaluated stopping power and range data available from the literature for hydrogen, carbon,
iron, and uranium projectile ions and target materials including water, carbon, aluminum,
lead, copper, iron, gadolinium, and gold.
5.2. Methods
5.2.1. State-of-the-Art Theories for Stopping Power and Projected Range
The most widely used method for calculating stopping power and range was developed
by Ziegler and colleagues over the last four decades. They wrote a computer program to
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conveniently calculate the Stopping and Range of Ions in Matter (SRIM) [172]. SRIM is
actively supported by Ziegler and colleagues, who provide annual updates to the program
based on evaluations of new measurement data and advances in stopping theory. In this
section, for the reader’s convenience, we will provide a brief overview of the methods used in
the SRIM code, which is representative of methods used for stopping power and calculations
in many basic and applied fields.
Total stopping power, S, is given by

S = Sn + Se

(5.1)

where Sn is the nuclear stopping power and Se is the electronic stopping power. Ziegler
and Biersack [172] developed a universal nuclear stopping theory for the calculation of the
nuclear stopping power for various ion species, ion energies, and targets. It is given by

Sn =

d Z2 z1 M1 Sn ()
(M1 + M2 )(z10.23 + Z20.23 )

(5.2)

where, the function Sn () is the reduced nuclear stopping power,  is the unitless reduced
energy, and d is a scaling coefficient [172]. z1 is the charge of the ion and M1 is the mass of
the ion. Z2 and M2 are the corresponding quantities for the target. These nuclear stopping
powers have been shown to match closely with measurements [172].
Electronic stopping powers are calculated diﬀerently depending on the energy regime. For
hydrogen ions with energies above 1 MeV/nucleon (defined as high energy), SRIM employs
the Bethe-Bloch formula with corrections or

Se,high



4πr02 NA ρ m e c2 z12 Z2 1
2me v 2
C
2
=
ln
− ln hIi − β −
+ Ln
M2
β2
1 − β2
Z2

(5.3)

where r0 is the classical electron radius, NA is Avogadro’s number, ρ is the mass density of
the target material, me is the mass of the electron, c is the speed of light, Z2 , z1 , and M2
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are as before, β = v/c, v is the ion velocity,hIi is the mean ionization potential, C is the
shell correction, and Ln is the sum of all the higher order corrections [172]. The higher order
corrections include the density correction, the Barkas correction, and the Bethe correction
[170]. C and hIi are normally treated as fitting parameters, allowing for adjustment of
the equation to match experimental data or alternative approaches to calculating stopping
powers [172].
Electronic stopping power in the low energy regime is a simple power law, or
Se,low = AE n ,

(5.4)

where A and n are fitting parameters. Se,low is used at ion energies below the target conduction band [172].
At intermediate energies a physical theory is not available. Instead, a “bridging theory”
is used, or
Se =

Se,low Se,mid
Se,low + Se,mid

(5.5)

where Se,low is the power law from equation 5.4 and Se,mid is a function used to fit the intermediate energies between the low energy formula and the Bethe-Bloch Equation. The
intermediate energy function is selected to provide optimal fitting of this region of the stopping power curve. ICRU Report 49 used a logarithmic function for fitting Se,mid [168]. The
functional form of this “bridging function” used in SRIM is proprietary. It is also necessary
to interpolate between the Bethe-Bloch equation, 5.3, and the “bridging theory” to produce
a continuous function, spanning a short energy interval between the intermediate to high
energy regime. Example boundaries of ion energy regimes for the ICRU formalism are shown
in Figures 5.1 and 5.2.
All of the electronic stopping power equations above are combined and then fit to experimental data. SRIM uses published measurements and evaluations of stopping powers in
various materials from many authors, where at least 9 free parameters are allowed to vary
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to match the theory to the experimental results [172]. An eﬀective charge scaling method
is used to convert hydrogen stopping powers to helium stopping powers [172] and, for ions
heavier than helium, hydrogen stopping powers are scaled using Brandt-Kitagawa Theory
[176].
Range is defined as
Z

E0

R=

S −1 dE

(5.6)

0

where S is the stopping power and dE is the diﬀerential energy. Evaluation of the definite
integral in equation 5.6 provides the total pathlength traveled by the particle, i.e., using
the straight-ahead approximation. Projected range additionally takes into account the eﬀect
multiple coulomb scattering and range straggling. SRIM uses the Projected Range Algorithm
(PRAL), developed by Biersack [177] to calculate projected range.
5.2.2. Proposed Analytical Model for Ion Stopping Powers and Projected Range
The proposed model is based on the Bragg-Kleeman (BK) Rule [173], or
R = αE p

(5.7)

where α and p are empirical constants and E is the particle energy in MeV. This empirical
formula has been shown to fit to an energy range of about 1-200 MeV for hydrogen ions
in water [178, 179] and has been used extensively in proton therapy for determining beam
energy requirements and water equivalent thicknesses [174, 175].
Bortfeld (1997) showed that the stopping power can be approximated from the BraggKleeman rule using:
dE
1
.
dx αpE p−1

(5.8)

The parameters α or p are obtained by fitting equations 5.7 or 5.8 to data from measurements,
theory, or evaluations [174] .
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In this work, we propose a new expression for stopping powers given by

Sp =

κ
G(Ê) + H(Ê) − J(Ê)

(5.9)

where κ is a constant, G(Ê) describes the low energy regime, H(Ê) describes the high energy
regime, and J(Ê) is a high energy correction, and Ê is defined as energy per nucleon, MeV
u-1 . κ is
κ = 2r02 ne me c2 z12

MeV cm-1

(5.10)

where r0 is the classical electron radius, me is the mass of the electron, b is the speed of
light, and z1 is the charge of the projectile. ne is the electron density of the target material,
or Na ρZ2 /M2 . G(Ê) corresponds to the low energy regime and is given by
G(Ê) = βq Ê q−1

(5.11)

where β and q are empirical fitting parameters.H(Ê) corresponds to the high-energy regime,
and is expressed as
H(Ê) = αpÊ p−1

(5.12)

where α and p are additional fitting parameters. Finally, J(Ê) corresponds to the ultra-high
energy regime and may be considered as a correction to H(Ê) (e.g., for the density eﬀect
and other higher order corrections) that helps fit stopping powers above 100 MeV u-1 . It is
expressed as


−g Ê

J(Ê) = h e


−1

(5.13)

where h and g are fitting parameters. By substituting equation 5.9 into Eq. 5.6 and integrating we obtain an expression for range given by
Z
R=
0

E0



1
1
h  −gÊ
q
p
=
β Ê + αÊ +
e
+ g Ê − 1 u
S
κ
g
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(5.14)

where κ and the fitting parameters are as defined previously and u is the atomic mass
number of the projectile. The factor of u arises from substitution of variables required for
the integration of Ê in equation 5.6.
5.2.3. Stopping Power and Projected Range data for Fitting
To test the performance equations 5.9 and 5.14 we selected hydrogen, carbon, iron,
and uranium ions due to clinical interest in radiation therapy, space radiation protection,
and basic physics. For hydrogen ions, the target materials were water, carbon, aluminum,
lead, copper, iron, gadolinium, and gold. For the other projectiles, the target materials
were water, carbon, aluminum, lead, and copper. For all ions and materials, we generated
the total stopping power and projected range data using SRIM 2012. The SRIM software
provides 26 energies per decade for its stopping power and range data output by default.
The lower bound of the energy interval for each ion and target combination was calculated
using
EL (keV) = 0.922 Z1 Z2



M1
+1
M2




Z10.23 + z20.23 ,

(5.15)

where, M1 , Z1 , M2 , and z2 are as previously defined. This approach follows from Equation
2-88 in Ziegler et al. (2012). A fixed upper energy bound was used for all targets of a
particular ion. Table 5.1 lists the energy intervals for all ions.
We generated data at 10 energy bins per decade within the energy intervals defined by the
minimum and maximum energies (table 5.1). Data was generated with variable logarithmic
spacing according to
Ê = 0.001 (MeV u-1 ) · 10i/B

(5.16)

where B is the number of energies per decade and i is the index of the ith data point. The
stopping power and range values at each ion energy were then extracted from the SRIM
data using a piecewise cubic Hermite polynomial interpolation, implemented in MATLAB®
(2012, The MathWorks Inc., Natick, Massachusetts, United States)
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Table 5.1. Energy cutoﬀs for each ion investigated in this study,
as well as, where this cutoﬀ occurs in range of the ion in water.
Projectile Ion

Hydrogen
Carbon
Iron
Uranium

Lower Energy
Bound (MeV
u-1 )
0.002
0.017
0.053
0.193

–
–
–
–

0.029
0.171
0.217
0.351

Upper
Energy
Bound (MeV
u-1 )
450
600
1400
2500

Upper
Range
(cm)
116
53
43
30

Note. The upper range column was rounded to the nearest centimeter. Lower energy limits are rounded to the nearest keV.

Uncertainties in the stopping power and range data from SRIM were estimated from the
ratio of data from PSTAR [180] to data from SRIM [172] . The resulting ratios were 5% or
less for Ê ≤ 1 MeV and 2% or less for Ê > 1 MeV. These ratios provide a good estimate
for the lower limit of the uncertainties because PSTAR and SRIM use diﬀerent calculation
methods, fitting techniques, and source data. The reduced uncertainty seen above 1 MeV is
due to the fact that the Bethe-Bloch Equation is used by both SRIM and PSTAR to generate
high-energy stopping power values.
5.2.4. Fitting Procedure
Fitting was performed using a hybrid genetic algorithm [181] implemented in commercial software (MATLAB Global Optimization Toolbox, The MathWorks Inc., Natick, Massachusetts, United States), to locate global minima. The algorithm was configured with a
population size of 1000, which was broken into 10 sub-populations, and was allowed to use up
to 1200 generations to converge on a solution. A constrained minimization (MATLAB Optimization Toolbox) was used to finalize the fit parameters. The objective function minimized
is given by
s
F OMi =

|Rf it,i − R|
∆R

2


+ 0.97

|Sf it,i − S| /S
∆S
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2


+ 0.03

max (|Sf it,i − S| /S)
∆S

2

(5.17)

Table 5.2. Constraints on fitting parameters provided to the hybrid genetic algorithm.
Bound β
Lower
0
Upper 0.8

r α
0 0
1 0.8

p
1
2.1

g
0
0.5

h
0
0.15

where |Rf it,i −R| represents the absolute value of range diﬀerence, |Sf it,i −S|/S represents the
absolute value of the relative stopping power diﬀerence, max ( |Sf it,i − S| /S) is the maximum
absolute value of the relative diﬀerence in stopping power, and ∆R and ∆S are criteria
parameters that govern the relative importance of the three terms in equation 5.17. The
values of criteria used were ∆R = 0.1 cm, and ∆S = 10%. The first two terms in the
objective function minimize the global deviations in both range and stopping power, while
the third term reduced local hotspots. The relative weight of the two stopping power terms,
in equation 5.17, was determined empirically to balance the eﬀects of the third term. We
applied constraints (table 5.2) to the fitting parameters to facilitate reliable optimization.
Due to the stochastic nature of the start points and the hybrid genetic algorithm, final
solutions occasionally converged on a solution that was outside of the expected results. To
avoid the impact of these outliers on final fitting parameters, each dataset was fit 35 times
and outliers were excluded using Chauvenet’s criteria [182, 183] .
5.2.5. Robustness to Sparse Data
We tested the model and fitting procedure for robustness to sparse data by varying the
number of energies per decade (B=1,2,4,6,…,26 in equation 5.16) for all datasets. Each set
of data points was fit 40 times and all the trials were run sequentially. As before, outliers
were rejected using Chauvenet’s criteria.
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5.2.6. Average Time Required to Compute Stopping Power and Range
Stopping power calculation times were recorded for the proposed analytical model (Eq.
5.9) and an in-house full theory model (Eqs. 5.2-5.5) to generate lookup tables of stopping
power. The lookup table was generated with energies defined by equation 5.16 using 28
energies per decade and 160 total energies.
Range calculation times were recorded for the analytical formula (Eq. 5.14) and, for
comparison, the numerical integration (NI) of equation 5.6. NI was performed using stopping
powers calculated on the fly with either the proposed analytical model or the full theory
model. Additionally, NI was performed using nearest neighbor interpolation from a fast
lookup table, which used the same energy grid as the stopping power tables.
Timing information was determined by using the minimum time of 10 trials, each consisting of 10,000 averages to overcome system timing limitations. Comparisons were performed
using in-house software developed in C++ and compiled with the Intel 2016 Compilers (Intel Corporation, Santa Clara, CA). Full Optimization (-O3) was utilized during compiling
and linking and the automatic parallelization was disabled. A personal computer running
Windows 10 Pro (build 14342, Microsoft Corporation, Redmond Washington) with a 4.05
GHz processor was used to collect timing information.
5.3. Results
5.3.1. Fitting Parameters for New Model
The parameters of the analytical model for each ion-target combination are listed in
tables 5.3 and 5.4. These parameters can be used in equation 5.9 to calculate stopping
powers or in equation 5.14 to calculate the range of the ion. Using these parameter values
with all of the significant digits listed in these tables will allow replication of our results to
within 0.1% for stopping powers or 7 m for range. The uncertainty in individual parameter
values due to the fitting procedure was less than 4% in all cases.
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Table 5.3. Parameters from fitting hydrogen and carbon stopping powers and ranges.
Material
H2 O
Carbon
Aluminum
Lead
Copper
Iron
Gold
Gadolinium

β (×10 )
3.1764
3.3753
4.2267
17.0464
12.8511
7.6905
19.5433
11.9556

q
0.4583
0.5050
0.4619
0.2332
0.5381
0.3141
0.2635
0.4262

Material
H2 O
Carbon
Aluminum
Lead
Copper

β (×10−5 )
26.1662
26.5006
41.1891
103.8596
71.5322

q
0.346
0.5221
0.6422
0.5369
0.4574

−5

Hydrogen
α (×10−4 )
1.3127
1.3509
1.9859
5.2020
2.6283
2.5231
5.2962
4.2390
Carbon
α (×10−4 )
1.2682
1.3069
1.3374
3.9312
2.3035

p
1.6493
1.6591
1.5648
1.4714
1.5724
1.5759
1.4539
1.4789

g (×10−2 )
2.1239
2.0452
2.7479
3.2305
2.6525
2.6049
3.3555
3.2748

h (×10−3 )
4.1618
4.2046
3.8267
3.6440
3.9419
3.8929
3.7148
3.6800

p
1.6391
1.6375
1.6714
1.5368
1.593

g (×10−2 )
2.4017
2.4551
2.2982
3.0039
2.7591

h (×10−3 )
3.966
3.8986
4.5151
4.0902
4.0453

Note. All significant digits provided should be used to create accurate stopping powers
and ranges.

Table 5.4. Parameters from fitting iron and uranium stopping powers and ranges.
Material
H2 O
Carbon
Aluminum
Lead
Copper

β (×10 )
667.2047
539.2538
253.2571
651.7461
817.2919

q
0.0461
0.0503
0.4511
0.3451
0.1272

Material
H2 O
Carbon
Aluminum
Lead
Copper

β (×10−5 )
2186.154
1734.845
2417.656
5866.977
8817.095

q
0.12
0.2086
0.226
0.1961
0.0741

−5

Iron
α (×10−4 )
6.0204
8.8684
3.7556
11.2829
10.6575
Uranium
α (×10−4 )
21.7563
19.8765
19.1826
45.5524
39.6814

p
1.2719
1.0907
1.4396
1.2839
1.2179

g (×10−2 )
3.5983
4.6477
3.3158
4.351
4.2673

h (×10−3 )
2.8844
2.7597
3.2088
3.1556
3.14970

p
1.1526
1.1803
1.2094
1.0922
1.0807

g (×10−2 )
3.391
3.4502
3.5016
4.4667
4.2152

h (×10−3 )
2.8531
2.7267
2.9827
3.1018
3.04543

Note. All significant digits provided should be used to create accurate stopping powers
and ranges.
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Table 5.5. Average and maximum relative stopping power diﬀerence between SRIM and the
proposed model for all ion/target combinations considered.
Ion
Material
H2 O
Carbon
Aluminum
Lead
Copper
Iron
Gold
Gadolinium

Hydrogen
Average
(%)
-0.44
0.40
0.06
0.37
0.01
-0.02
0.37
0.45

Max
(%)
8.10
-4.73
-3.13
-3.91
0.62
2.26
2.95
1.71

Carbon
Average
(%)
-0.13
0.02
-0.39
-0.03
-0.10
-

Max
(%)
-5.00
-2.93
-5.80
2.47
-1.52
-

Iron
Average
(%)
-0.28
0.29
0.14
0.13
0.72
-

Uranium
Max
(%)
-6.93
-2.28
-4.34
-2.37
3.81
-

Average
(%)
-0.41
0.17
0.10
0.07
0.38
-

Max
(%)
-6.16
-3.25
1.35
-2.42
-3.72
-

Table 5.6. Average and maximum range diﬀerence between SRIM and the proposed model
for all ion/target combinations considered.
Ion
Material
H2 O
Carbon
Aluminum
Lead
Copper
Iron
Gold
Gadolinium

Hydrogen
Average
(mm)
0.018
0.010
0.021
0.021
0.002
0.004
0.020
0.016

Max
(mm)
0.091
0.109
-0.194
-0.086
-0.019
-0.02
-0.113
-0.0981

Carbon
Average
(mm)
0.044
0.006
0.009
0.005
0.004
-

Max
(mm)
0.508
0.044
-0.046
-0.023
0.028
-

Iron
Average
(mm)
0.105
0.054
0.015
0.011
0.044
-

Max
(mm)
-0.392
-0.530
-0.113
-0.086
-0.332
-

Uranium
Average
(mm)
0.070
0.049
0.022
0.021
0.080
-

Max
(mm)
-0.206
-0.249
-0.085
-0.088
-0.295
-

5.3.2. Diﬀerence in Stopping Power and Range Values from SRIM and Proposed
Model
Tables 5.5 and 5.6 list the average and maximum errors for all ion and target combinations. The largest uncertainties in stopping power are associated with hydrogen ions in
water. The reasons for this will be addressed in the discussion section.
Figure 5.1 plots S(Ê) and the inverse of J(Ê), H(Ê), and G(Ê) for hydrogen ions incident
on carbon. The low-energy term closely matches the training data. The high-energy BK rule
is oﬀset from the training data but it is clear that the sum with the exponential term reduces
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Figure 5.1. Components of the proposed stopping power equation, 5.9, for the stopping
power, S, of hydrogen ions in carbon as a function of ion energy, Ê. The figure is divided
into the four regimes, as defined by the vertical bars, whose energy values were taken from
ICRU Report 49 (1994) to construct their stopping power curves. The solid line represents
the complete fit model. H(Ê) is represented by the dashed line. The dash-dot line is the
high energy term, G(Ê). The exponential term, J(Ê), is shown as the dotted line. The data
presented here is for hydrogen ions in copper.
the stopping power to match the base data. Similarly, figure 5.2 reveals good agreement
in range values and how each component of the model contributes to the projected range
calculation.
Figures 5.3(a) and (b) plot of stopping power and range values for hydrogen ions in water.
This was the data with the worst overall agreement in stopping power value. The maximum
relative diﬀerence in stopping power values was 8.1%. Interestingly, this diﬀerence occurred
at the ion energy interval where SRIM interpolates between intermediate and high energy
stopping theories, which may introduce small, non-physical artifacts in the curve. This
worst-case result for stopping power values is still less than the stated goal of 10%. Figures
5.3(c) and (d) plot stopping power and range for carbon ions in copper. These figures reveal
excellent agreement between data from the analytical model and SRIM, with diﬀerences in
stopping power values of less than 2% and range diﬀerences of 3 m. Figures 5.4(a) and (b)
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Figure 5.2. Components of the proposed range equation, 5.14, for the range, R, of hydrogen
ions in carbon as a function of ion energy, Ê. The figure is divided into the four regimes, as
defined by the vertical bars, whose energy values were taken from ICRU Report 49 (1994)
to construct their stopping power curves. The solid line represents the complete fit model.
H(Ê) is represented by the dashed line. The dash-dot line is the high energy term,G(Ê).
The exponential term, J(Ê), is shown as the dotted line. The data presented here is for
hydrogen ions in copper.
plot stopping power and range values for iron in carbon. This worst-case result for range
values (0.53 mm maximum diﬀerence) is still less than the 1 mm goal of this work. Finally,
Figures 5.4(c) and (d) plot stopping power and range for uranium ions in aluminum. These
data once again show excellent agreement between data from the analytical model and the
SRIM data, with stopping power diﬀerences less than 1.5% and range diﬀerences less than
0.1 mm.
5.3.3. Robustness to Sparse Data
Figure 5.5 plots the maximum diﬀerence in range and stopping power versus the number
of energy values per decade for a few representative ion-target combinations. The data
reveals that with 4 or more energies per decade, the criteria of 10% stopping power difference and 1 mm range diﬀerence were met. The diﬀerences also were stable between 4 and
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Figure 5.3. Stopping powers, S, and ranges, R, versus energy, Ê, for hydrogen ions in water
((a) and (b)) and carbon ions in copper ((c) and (d)). The solid line represents the proposed
model. The dashed line is the absolute value of the diﬀerence in range, |∆R|, or the relative
diﬀerence in stopping powers, ∆S/SSRIM , and are associated with the axis on the right. The
circles represent the data points used in the fitting.
26 energies per decade, never varying by more than 1% in stopping power or 0.25 mm in
range.
5.3.4. Average Time Requires to Compute Range and Stopping Power
The proposed analytical model for stopping power was faster than a full theory based
calculation. The calculations of 160 values took 10.7 s with the proposed analytical model
versus 15.1 s with the full theory, corresponding to a 28% reduction in computation time.
The proposed analytical range model was the fastest approach to calculate range. Table
5.7 shows the timing results for all of the numerical integration tests and the analytical
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Figure 5.4. Stopping powers, S, and ranges, R, versus energy, Ê, for iron ions in carbon
((a) and (b)) and uranium ions in aluminum ((c) and (d)). The solid line represents the
proposed model. The dashed line is the absolute value of the diﬀerence in range, |∆R|, or
the relative diﬀerence in stopping powers, ∆S/SSRIM , and are associated with the axis on
the right. The circles represent the data points used in the fitting.
model. This data demonstrates that the analytical range model performs calculations at
least 945 times faster than any numerical integration (NI) approach tested in this work. The
data also demonstrates a fast lookup table is only 34% faster than on-the-fly calculations
using the proposed model. Using the proposed model to calculate stopping powers is 38%
faster than using the full theory model when performing NI.
5.4. Discussion
In this study, we developed a simple analytical expression for calculating stopping power
and projected range. We evaluated the new model’s ability to fit evaluated stopping powers
and projected ranges, robustness to sparse data, and computational speed. The model was
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Figure 5.5. The two panels above show the maximum stopping and range errors versus
the number of energy points per decade for a representative collection of ions and target
materials. The data for carbon ions in water, iron ions in aluminum, and uranium in carbon
are represented by circles, squares, and diamonds respectively. Error bars represent one
standard deviation of the 40 trials run to collect each data point. Diﬀerent features of these
datasets are discussed in the text.
Table 5.7. Computation time and speedup of range calculations.
Model
Time (s)
Analytical range
0.048
NI: Full theory stopping power
107.859
NI: Analytical stopping sower
67.390
NI: Lookup table stopping power 45.000

Speedup
1
2267
1416
946

Note. The first row shows the results of using the analytical model to find the range, which is used as the timing
standard. Rows representing numerical integration (NI)
specify the stopping power model used in the integration.
Speedup is defined as Ti /TA where Ti is the time of the
method andTA is the time using the analytical range model.

fit to evaluated stopping powers and ranges with better than 8.1% accuracy in stopping
powers and less than 0.6 mm in range for hydrogen, carbon, iron, and uranium projectiles
in water, carbon, aluminum, lead, copper, iron, gadolinium, and gold for all ion energies
investigated (an interval of at least 351 keVu-1 to 450 MeV u-1 ). The model and fitting
procedure are robust to sparse data, requiring only 4 energies per decade to produce results
with less than 10% relative diﬀerence in stopping power or 0.53 mm in range. The proposed
range model demonstrated a reduced computation time, when compared with numerical
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integration. Additionally, it was shown that the analytical stopping power was nearly as fast
as the approach of using pre-calculated values and fast lookup tables.
The implication of the findings of this study include the possibility to increase speed
and/or accuracy of charged particle transport calculations. One application is the calculation
of clinical water equivalent thickness and stopping power ratios, as demonstrated by Zhang
and Newhauser [174], with an expanded interval of ion-energy applicability. The proposed
model overcomes many of the limitations presented in their study by improving the accuracy
of the model over a wider range of energies. Memory-constrained GPU-based dose calculation
algorithms may also benefit from the proposed model. The proposed stopping power model
used only 2% of the memory required to store a lookup table. This approach could enable
GPU-based algorithms to increase calculation accuracy by increasing the number of materials
that can be stored in the unit memory and speed by reducing the amount of information
that needs to be transferred to the GPU. Additionally, the model parameters can be used
to calculate the range of the particles at no additional memory cost.
The results from our study are consistent with those from Zhang and Newhauser [174]
and Zhang et al. [175]. In their work, they fit a single Bragg-Kleeman Rule to hydrogen,
helium, carbon, and iron stopping powers for energies between 10 and 250 MeV u-1 . Using
their model with the fitting procedure and data used in this study in that energy interval, the
maximum relative diﬀerence produced was 9%. In this work, the maximum relative diﬀerence
was reduced to less than 0.3%. Outside of the 10 to 250 MeV u-1 interval, a single BK rule
is not applicable whereas our model performed well in the energy range from 1 keV to 450
MeV u-1 . Konac et al. [184] proposed another parameterization of electronic stopping powers
for heavy ions. In their work they fitted stopping powers of ions ranging from hydrogen to
bismuth in carbon and silicon targets in the energy interval from 0.01 to 100 MeV u-1 . They
were able to achieve uncertainties of less than 10% for all of their tested ions with only 6
free parameters. In this work, our model had a maximum stopping power uncertainty of less
than 9% in the ions and targets investigated, with a larger range of applicability of target
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materials. Of all of the stopping power models reviewed [184–189], none of them provided
an analytical equation for calculating range using the same parameters provided by their
stopping power model.
The major strength of this study was the wide variety of projectile ions and target
materials used in training and testing the model. The four ions selected span the periodic
table demonstrating the broad applicability of the model. A second strength of this study
was the use of a stochastic fitting algorithm to reliably find the global minimum values during
optimization.
A limitation of this work is our model did not explicitly attempt to take into account
Bragg additivity or molecular bonding eﬀects when modeling compounds and mixtures. This
limitation is not serious because these eﬀects may be taken into account in the input data,
e.g. implicitly in measured data or explicitly when the using molecular bonding theory
contained in SRIM, used in the fitting procedure. Additionally, the proposed model does
not explicitly calculate losses due to radiative processes, e.g. bremsstrahlung. This is not
a significant limitation because the model is not applicable in the energy regime where
radiative losses become important, i.e. ~100-1000 GeVu-1 [169, 190]. This is due to the
radiative losses being inversely proportional to the square of the ion mass. Finally, this work
did not perform exhaustive fitting of ion species and target materials. This is not a severe
limitation because the cases considered are representative, demonstrate broad applicability,
and users may easily apply our method to arbitrary cases.
A possible future extension could be to develop a parameterization of the fitting parameters (α, p, β, q, g, and h) based on target material and ion properties. If the fitting
parameters could be calculated using physical quantities, this would improve convenience
and applicability. In addition, the model could be further extended to increase the energy
interval of applicability, especially in the high-energy regime. Finally, further investigation
into the computational performance and optimization of the model should be performed.
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This study has shown that a simple, continuous analytical model can be fit to evaluated
data to provide stopping power and range data of reasonable accuracy for various applications. The faster computation speed compared to a full theoretical model and the smaller
memory footprint compared to lookup tables may enable improvements in limited memory
parallel computing applications.
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6. Computational Feasibility of Simulating Changes in Blood Flow
through Whole-Organ Vascular Networks from Radiation Injury
6.1. Introduction
The circulatory system comprises the heart, lungs, arteries, capillaries, and veins, which
delivers blood to most tissues in the body [76]. Capillaries, which facilitate the transfer
of oxygen and nutrients from the blood to the surrounding tissue, determine the local and
regional blood flow of organs [14]. Radiation injury of vessels can lead to beneficial and detrimental responses [5, 11, 191]. For example, radiation therapy prunes tumor blood vessels,
reducing the amount of oxygen and nutrients deliver, eﬀectively causing the tumor to stave.
However, radiation necrosis, a potentially fatal side-eﬀect which occurs in approximately 5%
to 25% of patients [6], has been correlated with increased vascular abnormalities caused by
radiation injury [10, 11]. Histologic and clinical techniques have been used to study necrosis,
with limited success toward understanding the complex sequence of events between vascular
injury and the onset of necrosis [10, 11]. Computer simulations could, in principle, elucidate the key determinants of the response to vascular injury, including reduced blood flow,
modification of the tumor micro-environment and induction of necrosis. Such simulations
would, by necessity, entail modeling physical aspects, such as vascular geometry, radiation
dosimetry, and blood flow, as well as radiation biology.
Much is known about each of these modeling methods and progress in recent years has
been remarkable. The human brain contains up to 9 billion vessels, forming the densest
vascular network of the body [12, 62]. The feasibility of simulating the vascular geometry
(Chapter 2) [132] and blood flow (Chapter 3) [160] through networks with up to 17 billion
vessels was recently demonstrated. Radiation injury of the capillaries, which are only micrometers in size [12, 77], requires radiation transport modeling on the same scale. Monte
Carlo simulations are the most realistic way to simulate radiation dose deposition at microscopic or macroscopic scales [32, 192–194], yet it remains computationally prohibitive to

83

simulate all relevant dimensional scales simultaneously. This limitation if frequently overcome by using amorphous track-structure models, which provide a faster but slightly less
physically realistic approach to simulating radiation dose [34, 35, 195]. Irradiation of a blood
vessel causes a biologic response in the vessel’s function and structure, including increased
permeability, loss of elasticity, and pruning of the vascular tree [40–42, 196]. Recently, some
progress has been made in understanding the mechanistic processes behind these manifestations of injury [197–199], primarily regarding the cellular mechanisms and local changes
in blood flow. Computational techniques for modeling both dose deposition and biologic
response have been applied in small volumes of tissue to investigate the eﬀects of radiation
on the tumor micro-environment [200, 201]. However, little attention has been paid in the
literature to simulations of the eﬀects radiation has on the vascular networks of whole organs. It is currently unknown if it is computationally feasible to simulate the radiation dose
to individual blood vessels and model their biological changes in a network the size of the
human brain.
The goal of this work was to test the the computational feasibility of simulating the dose
deposition to a whole-organ vascular network and the resulting change in blood flow. To
do this, we developed a new amorphous track-structure model to transport radiation and
combined this with previously described methods to model the vasculature and blood flow
rates (Chapters 2-4). We assessed the algorithm’s execution time, computational scalability,
and memory usage.
6.2. Methods
6.2.1. Geometry Description
The vascular geometry was created using fractal methods (Chapter 2) [132] and then
partitioned to create a computationally efficient data distribution (Chapter 3) [160]. The
geometric model described each vessel’s start point, end point, and inner radius. In the
model, each parent vessel branches into two child vessels. The smallest vessels in the network
were 2.5 µm in radius and 55 µm in length [12]. Between each generation, the vessel radius
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was reduced by 2−1/3 following Murray’s Law for bifurcation [93] and the length was reduced
by 0.8 to reduce vessel overlap for visualization [132]. The vascular networks were created
in 2-D (for visualization) and 3-D for use in the radiation dose calculation (Figure 6.1). An
bounding box that describes the maximum extents of the vascular network was also included
in the model.
6.2.2. Dose Calculations
6.2.2.1. Radiation Transport
To test the computational feasibility of the dose calculations, we simulated proton tracks
traversing a vascular geometry. The source comprised a beam of protons propagating in
the -z direction from a rectangular field above the network (Figure 6.1). We limited the
beam laterally to exclude the six largest vessels in the network (Figure 6.2). This was done
to exclude large regions of the simulation volume where no vessels exist, which decreased
simulation times. The start position of each proton was determined stochastically by uniform
sampling from within the field (see Figure 6.2). The initial direction of proton travel was

Figure 6.1. Illustration of 2-dimensional (a) and 3-Dimensional (b) versions of a 30-vessel
network created using the methods of Donahue and Newhauser [132] (Chapter 2)
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Figure 6.2. An example of the field size (crosshatched area) used in the dose calculation
algorithm for an example network with 126 vessels from beams eye view. The 2-dimensional
network was used for visual clarity.
stochastically sampled uniformly from a cone with an half-angle of 4 degrees. The initial
starting energies of the protons were stochastically sampled from a Gaussian with a width
(σ) of 1 MeV and mean value equal to the nominal beam energy (E0 ).
We transported the protons using a simple analytic model. Proton energy loss was modeled with the continuous slowing down approximation. Lateral scattering, energy straggling,
and nuclear reactions of the protons were neglected to decrease simulation times. Stopping
powers were calculated using the methods of Donahue et al. [167] (Chapter 5) on the assumption that the vascular networks and surrounding tissue were water. Each proton track
was represented by a list of points along a linear trajectory, where the proton kinetic energy
and coordinate were recorded for each point. Using the mass stopping power, S, at the
current point, the distance to the next point was calculated using an adaptive step size of

∆x =

0.05E
ρS
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(6.1)

where E is the current proton energy and ρ is the material mass density. Each proton was
transported until the particle track exited the simulation volume or its energy fell below a
cutoﬀ of 5 keV, at which point the residual energy was deposited locally. Each proton track
was surrounded by a bounding cone with a base radius equal to the maximum δ-ray range
of the initial proton energy. To calculate the maximum range of the δ-rays in water, we fit
an emperical formula to the calculated results from Waligórski et al. [34] for proton energies
from 1 keV to 350 MeV, or


rmax = 9.9420 × 10−4 · E 1.0225 + 1.4479 × 10−3 · E 1.7792

(6.2)

where E is the proton energy in MeV.
We modeled the dose deposition of a proton track and its secondary particles using an
amorphous track-structure model by Elsässer et al. [35]. This model considers the dose
deposition from the proton core and, separately, from the halo of δ-rays. The dose deposited
by the δ-rays is approximated to the radially symmetric (Figure 6.3). The model used was

D(r) =




2
λS/rmin




2
λS/r





0

r ≤ rmin
rmin < r ≤ rmax

(6.3)

r > rmax

where r is the radius from the proton track to the dose calculation point, rmin is the core
radius, rmax is the maximum δ-ray range (Equation 6.2), S is the mass stopping power of
the proton, and λ is an empirical normalization factor. The normalization factor forces the
total energy lost by the proton to be equal to the dose absorbed in the medium from the
track’s core and halo. It was calculated following the method of Elsässer et al. [35], or
λ = (π [1 + 2 ln (rmax /rmin )])−1 .
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(6.4)

Figure 6.3. An illustration of proton track structure (a) and an amorphous track structure
model (b) for a proton traveling toward the bottom of the page. Panel (c) plots the actual
track structure model used in this work for various proton energies.
The core radius was
rmin = 1.8428 × 10−6 · E 0.4984



(6.5)

where E is the proton energy in MeV [35].
Finally, a k-d tree was constructed for each proton track [202, 203]. The k-d tree provided
an efficient method for finding the nearest point in the line of points to any arbitrary point
in the geometry. This improved the computation speed of the dose calculations.
6.2.2.2. Dose Scoring
We scored the radiation dose to the endothelial cell layer of the vessel walls. We split
the tube-shaped geometry of each vessel into 10 axial segments. For each of these segments,
eight dose points were evenly spaced around the midline, forming a ring. Radiation absorbed
doses were scored to each of the 80 points.
To efficiently score dose from a proton track to the non-rectilinear geometry of a blood
vessel, we used a recursive approach (Figure 6.4). First, the bounding cone of the particle track and the bounding box of the vessel were checked for any intersection. If they
overlapped, the dose was calculated at all eight corners of the vessel bounding box and its
centroid. The dose at each corner was compared to the dose at the centroid to determine uni88

formity. If all the corner doses were equal to the centroid dose (within ), then the centroid
dose was scored for all sub-volumes in the vessel (Figure 6.4b). Otherwise, the doses were
calculated to determine if the dose was uniform in each axial segment in the vessel (Figure
6.4c). The bounding shape for each axial segment was a 2-D square that encompassed the
circular cross-section of the vessel and contained 8 dose points. If the dose was not uniform
(Figure 6.4e), the dose was calculated to all 8 dose points in the segment individually. We
selected  to be 50% for this work to limit recursion and the associated simulation time.
6.2.2.3. Algorithm Implementation
The calculation of radiation dose from a proton to a blood vessel is an embarrassingly
parallel problem. We separated the algorithm into three applications to facilitate efficient
parallel computations (Figure 6.5). These applications together calculated the dose to the
vascular network contained in the vessel data file. Details of each of these applications is
discussed in the remainder of this section.
The first application (Dose Initialization) prepared the vessel data file for the dose calculations by adding beam parameters to file and dividing up the problem for distributed
parallel computations. For distributed parallel computations, we divided the blood vessels
into Nb blocks, where each block consisted of nv vessels selected contiguously from the vessel
data file. The number of blocks in a computation depended on the number of compute
nodes, Nc , used, or
Nb = 16Nc .

(6.6)

Each vessel block was processed by a separate instance of the Dose Calculation application,
where each instance was run simultaneously on a separate computer. We used 16 blocks of
vessels per compute node to facilitate load balancing across a distributed-computing environment. Because the geometry data was partitioned geometrically, each vessel block contained
vessels that were spatially clustered together. Additionally, the Dose Initialization application reserved the cumulative dose-output storage structures in the vessel data file and created
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Figure 6.4. Flow chart of the recursive dose algorithm (a). Panels b-e illustrate specific
branch cases of flow chart. The red arrows represent the core of a proton track and the color
washes represent dose to the vessel (from δ-rays) or segment. Panels d and e represent the
cross-section of an axial segment of a vessel.
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Figure 6.5. A flowchart of the dose calculation algorithm.
the simulation volume. The simulation volume was constructed by extended the vascular
network bounding box to include the specified radiation field. The Dose Initialization application accepted command line arguments to specify the beam parameters and the size of
vessel blocks (listed in Table 6.1). All proton beam and vessel block parameters were stored
in the vessel data file.
The Dose Calculation application computed the dose from proton tracks to each block
of vessels. The inputs for this application included the vessel data file to be processed,
index of the vessel block to be processed, and the number of proton tracks to be simulated.
To begin, the Dose Calculation application loaded the geometric description of its assigned
vessel block from the vessel data file. For each vessel, we calculated the thickness of the
layer of endothelial cells, tW , by adapting the the equation published by Blanco et al. [104]
to include a lower limit to the thickness, thus better modeling the the wall thickness of
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Table 6.1. List of input parameters and their acceptable domains of the Dose Initialization.
Parameter
field_size_width
field_size_height
field_dir_x

Acceptable Range
0 to maximum extent of network
0 to maximum extent of network
0 to 1

field_dir_y

0 to 1

field_dir_z

0 to 1

field_center_x
field_center_y
field_center_z
energy
num_chunks

x extents of network
y extents of network
z extents of network
1 to 350
1 to 32,000

Units Description
mm Specify field width
mm Specify field height
arb. x component of direction
unit vector
arb. y component of direction
unit vector
arb. z component of direction
unit vector
mm x component of field center
mm y component of field center
mm z component of field center
MeV Nominal beam energy
arb. Number of vessel blocks

capillaries [12, 77], or

tW (mm) =




0.001

rV ≤ 0.1 mm



rv (0.2802rv−0.5053 + 0.1324rv−0.01114 )

rv > 0.1 mm

(6.7)

where rv is the inner radius of the vessel. Each vessel was surrounded by an oriented bounding
box that encompassed the vessel’s maximum dimensions. This was necessary to perform
efficient calculations of the interactions of particle tracks and blood vessels. A bounding box
was constructed to describe the maximum extents of the vessel block. Proton transport was
performed using the methods described in Section 6.2.2.1. To minimize the memory usage
of the application, the transport was stopped after 100,000 proton tracks intersected the
bounding box of the vessel block or all proton tracks were simulated. Dose from the block of
protons was calculated to each vessel in the vessel block (Section 6.2.2.2). If more protons
required transport, the algorithm created another proton block and repeated the dose scoring
process until all protons were transported. The doses calculated to the blood vessels were
written a new temporary dose file for the processed vessel block. The dose calculations and
radiation transport for each proton block were performed using shared-memory parallelism.
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We used an open-source utility [204] to distribute the invocations of the Dose Calculation
application across Nc compute nodes, facilitating the parallel processing of the vessel blocks.
The utility provided load-balancing capabilities to efficiently use all compute nodes.
The third application (Dose Merge) combined the results of the Dose Calculation application’s output files into the vessel data file. This was done by accumulating the doses from
each temporary dose file into the vessel data file for the entire vascular network. This step
ensured that the calculated doses were correctly combined during the parallel computations.
After calling this application, the vessel data file contained all dose information and the
temporary dose files were deleted.
6.2.3. Biological Response Modeling
We modeled the radiation-induced injury to a blood vessel as a uniform reduction in
radius throughout an entire vessel. For simplicity, we assumed that the length and wall
thickness of each vessel remained constant. The relationship between the healthy and damaged radii of a vessel was
rd = rh Q(D)

(6.8)

where rd is the radius of a damaged vessel, rh is the radius of a healthy vessel, and Q(D) is
the damage factor at dose D. D was the mean vessel dose.
To determine the damage factor, we fit experimental data for the relative change in vessel
surface area of rabbit ear vasculature (Figure 6.6) [40]. The data were stratified into capillary
and larger vessel strata, and each strata was fit separately The damage factor, Q(D), was




0.601 + 0.399e−0.00256D
for rh ≤ 10 µm





Q(D) =
−2.461 × 10−11 D3 + 1.306 × 10−7 D2


for rh > 10 µm




−4

− 1.605 × 10
D + 0.988
where D was the mean dose to the blood vessel in cGy.
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(6.9)

Figure 6.6. A plot of the dose response model (lines) and the experimental measurements
(markers) from Dimitrievich et al. [40] versus dose. The solid line and triangles correspond
to the capillary data, while the dashed line and squares correspond to the larger vessel data.
Equations 6.8 and 6.9 were implemented in the Dose Merge application. The damaged
vessel radii were stored in the vessel data file for subsequent use in the blood-flow rate
calculations.
6.2.4. Measurements of Computational Feasibility
6.2.4.1. Computational Resources
We used the SuperMIC cluster at Louisiana State University to perform all the computations in this work. This shared resource consists of 360 compute nodes, each containing
two 10-core processors (2.8 GHz Xeon E5-2680, Intel Corporation, Santa Clara, CA, United
States) and 64 GB of electronic memory. A high-performance network system (Infiniband
Interconnect, [98]) connects the compute nodes and provides access to a persistent storage
system (Lustre file system [99]), that enables up to 16 compute nodes to simultaneously read
from and write to the same file.
We compiled all software used in this study using commercial C++ compilers (Intel C++
Compiler Cluster Edition v18.0, Intel Corporation, Santa Clara, CA, United States). The
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compiler provided an implementation of OpenMP [94] for use in shared-memory parallelism
and implementation of the message passing interface (MPI) for all distributed memory communication (Intel MPI v18.0, Intel Corporation, Santa Clara, CA, United States).
All input and output (I/O) operations to persistent storage utilized the Hierarchical Data
Format version 5 (HDF5) library [139]. Our applications used the parallel I/O capabilities
of the HDF5 library and the Lustre file system to increase speed. The library was tuned to
the local file system following the suggestions of Howison et al. [97].
6.2.4.2. Execution Time
Execution time is an important performance characteristic of computationally demanding
applications. We developed an empirical formula to predict the execution times of the dose
calculation algorithm (T ) based on three simulation parameters: number of vessels (Nv ),
number of particles (Np ), and nominal beam energy (E0 ). To estimate the execution time
we used
T = T0 · V (Nv ) · P (Np ) · F (E0 , ns (E0 , Nv ))

(6.10)

where T0 is the baseline execution time in core hours, V (Nv ) is the vessel scaling function,
P (Np ) is the particle flux scaling function, and F (E0 , ns (E0 , Nv )) is the particle energy
scaling function. T0 was the execution time to perform a simulation with 2 million vessels
and 100,000 100-MeV protons. The scaling factors adjust the baseline time for diﬀerent
simulation-parameter combinations. The vessel scaling function, V (Nv ), adjusted the time
for the number of vessels and was
V (Nv ) = aNvb + c
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(6.11)

where a, b, and c are empirical fitting parameters. The particle flux scaling function, P (Np ),
adjusted the time for the number of protons simulated. The equation was
P (Np ) = f Npg + h

(6.12)

where f , g, and h are empirical fitting parameters. F (E0 , ns ) scales the baseline execution
time with the initial proton energy. We empirically determined the form of this scaling
function to be
F (E0 , ns ) = (kE0m + jE0q ) · log(ns (E0 , Nv ))

(6.13)

where ns is the average number of steps in a particle track and k, m, j, and q are empirical
fitting parameters. ns was determined by counting the number of steps a nominal energy
proton needed to cross the simulation volume or run out of energy.
Each scaling function was trained independently to quantify its eﬀect on the execution
time. Data was collected for each function by changing only the corresponding dependent
variable from its baseline condition. We collected each measurement three times and computed the average to account for system variations. Fits were performed using an open-source
least-squares fitting algorithm (curve_fit, Numpy v1.13, [205]). The vessel scaling data was
collected for 14 ≤ NV ≤ 4 × 109 . Multiple compute nodes were required for calculations with
NV > 33.5 × 106 . The particle flux scaling data was obtained for 100 ≤ NP ≤ 106 on a single
compute node. The initial proton energy data was collected on a single compute node for
nominal proton energies of 1 ≤ E0 ≤ 350 MeV.
We validated equation 6.10 against an independent set of execution time trials. These
measurements were selected to probe a wide range of parameter combinations (Table 6.2).
We calculated absolute and relative diﬀerence between the predicted and observed execution
times to determine the accuracy of the execution time model.
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Table 6.2. List of input parameters for the validation trials. Nv is the
number of vessels in the network, Np is the number of protons tracks,
E0 is the nominal beam energy of the protons, Nc is the number of
compute nodes, and Nb is the number of vessel blocks.
Trial No.
Nv
Np
1
126
100
2
1022
16,000
3
4094
100,000,000
4
16,382
300,000
5
262,142
10
6
2,097,152
1,000
7
4,194,302
200,000
8
4,194,302
1,000,000,000
9
4,294,967,294
2,000,000
10
8,589,934,590
500,000

E0 (MeV) Nc
Nb
10
1
16
350
4
64
75
32 512
350
1
16
250
2
32
50
1
16
1
1
16
140
128 2048
180
128 2048
180
128 4096

6.2.4.3. Computational Scalability
Computational scalability is an important performance characteristic of relevance to applications that utilize parallel computations. Computational scalability was characterized
by two widely-used metrics known as weak and strong scaling [144].
Weak scaling characterizes the execution time as the number of processors increases
and the amount of work per processor remains constant. In this work, this means that
the number of vessels doubled as the number of processors doubled. In the ideal case, the
execution time remains constant. This metric provides information on how the application
scales with problem size.
Strong scaling is a metric to characterize the ability for additional compute nodes to
decrease the execution time of a fixed problem size. The primary metric of strong scalability
is speedup (S), or
S=

T1
Tn

(6.14)

where T1 and Tn are the execution times of one and n compute nodes, respectively. We used
1 to 128 compute nodes to simulate the dose to the blood vessels for two diﬀerent networks
sizes: 2 million and 33 million vessels. The 2-million-vessel network was used to probe the
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eﬀects of problem size on strong scaling. A 33-million-vessel network was the maximum size
that could be processed on a single compute node. If the speedup factor is equal to the ratio
of the number of compute nodes (n) then the algorithm is considered to scale strongly.
Scalability of the Dose Calculation application was assessed because it predominated
the overall execution time. The scalability was only measured relative to the number of
vessels simulated, i.e., the number of particles and initial energy remained constant for each
measurement.
6.2.4.4. Memory Usage
Memory usage in a computer program is an important factor to understanding the performance of an application on a single compute node. Ideally, applications use as little memory
as possible and in the worst case as much as is available on the system. Memory usage was
measured for all three applications using an open-source profiling tool [100] for multiple trials
(Table 6.3). For the Dose Calculation application, we recorded the peak and mean memory
usage per vessel block processed. The peak and mean memory usage per compute node was
recorded for the Dose Initialization and Dose Merge applications. The peak memory usage
was used to determine if the application was ever limited by the amount of system memory.
The mean memory usage was used as a measure of how much memory was needed to run
the application.
Table 6.3. List of input parameters for the memory profiling
trials. Nv is the number of vessels in the network, Np is the
number of protons tracks, E0 is the nominal beam energy of
the protons, Nc is the number of compute nodes, and Nb is the
number of vessel blocks.
Trial No.
1
2
3
4
5

Nv
32,768
32,768
33,554,432
33,554,432
2,147,483,648

Np
10,000
200,000
1,000
10,000
10,000
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E0 (MeV) Nc
350
1
10
2
250
1
150
2
150
128

Nb
16
32
16
32
2048

6.2.5. Simulation of Radiogenic Changes of Blood Flow in an Entire Organ
To evaluate the potential utility of the dose algorithm in, for example, a radiobiological
study, we calculated the changes to blood flow in an organ-size vasculature following partialorgan irradiation. To achieve this, we assembled a modular workflow of algorithms (Figure
6.7). This workflow combined methods to construct vascular geometry (Chapter 2) [132],
calculate dose and change in radius (Section 6.2.2), and calculate the blood flow rates through
whole-organ vascular networks (Chapter 3) [160]. The details of the geometry algorithm were
reviewed briefly in Section 6.2.1.
For the convenience of the reader, a brief review of the blood flow algorithm is presented
here. Blood-flow rates in the vascular network were calculated using a steady-state bloodflow model. A steady-state model ignores the time-dependent evolution of blood flow and
assumes laminar flow. The steady-state blood flow is described by Pouiseuille’s equation, or

Q=

πr4
(Pin − Pout )
8ηl

(6.15)

where Q is the volumetric flow rate, r is the vessel’s inner radius, η is the viscosity of
the blood, l is the length of the vessel, and Pin and Pout are the pressures at the input and
output of the vessel, respectively [21]. Applying this equation to all blood vessels in a network
resulted in a system of linear equations, which we solved using numerical techniques [134].
We used this model to calculate the blood-flow rates through unirradiated and irradiated
vessels.
We evaluated the mean execution time to simulate changes in blood flow rates for whole
human brains and whole rodent brains. Table 6.4 lists the relevant simulation parameters
used in the study. To complete the computations in a network with 8.5 billion vessels, the
number of blocks per compute node was set to 32 in equation 6.6. This was necessary to
overcome the limitations in the I/O library used. We measured the overall execution time
of the workflow three times for each trial configuration.
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Figure 6.7. A flowchart of the workflow to simulate changes in blood flow due to radiation
damage.
6.3. Results
6.3.1. Dose Calculation Feasibility
6.3.1.1. Execution Time
We fit the scaling function (Equations (6.10) to (6.13)) to the training data to determine
the empirical parameters of the model of execution time (Table 6.5 and Figure 6.8a-c) with
Table 6.4. List of input parameters for the workflow trials. Nv is the number of
vessels in the network, Np is the number of protons tracks, E0 is the nominal beam
energy of the protons, Nc is the number of compute nodes, and Nb is the number of
vessel blocks.
Trial No. Model
Visualization Only
1
Mouse Brain
2
Human Brain
3
Human Brain

Nv
126
4,194,302
4,294,967,294
8,589,934,590

100

Np
E0 (MeV) Nc
Nb
10000
80
1
16
1,000,000,000
140
128 2048
2,000,000
180
128 2048
2,000,000
180
128 4096

Table 6.5. Fitting parameters for the timing
model to predict dose calculation times (See
Equations (6.10) to (6.13))
Parameter
T0
a
b
c
f
g
h
k
m
j
q

Scaling Factor
Value
Baseline Time 9.96 core-hours
V (Nv )
1.113 × 10−5
V (Nv )
0.716
V (Nv )
2.5 × 10−2
P (Np )
9.642 × 10−6
P (Np )
1.004
P (Np )
1.113 × 10−2
F (E0 , ns )
5.315 × 10−2
F (E0 , ns )
7.973 × 10−1
F (E0 , ns )
3.160 × 10−5
F (E0 , ns )
2.125

good agreement. More specifically, the model agreed with measured times from the validation
trials (Figure 6.8d) within a factor of 3.3 across approximately 5 decades of execution times.
The discrepancies can be attributed, in part, to the correlations between the various scaling
functions that were not taken into account, e.g., vascular density and maximum δ-ray range.
The agreement suggests the model to estimate the execution time is sufficiently accurate for
designing computational experiments.
6.3.1.2. Computational Scalability
We characterized the strong and weak scaling of the Dose Calculation application (Figure
6.9). The weak scaling data (Figure 6.9a) shows a decreasing trend in execution time. Thus,
for a fixed number of protons the application ran faster as the number of vessels and the
number of processors increased. These results imply that the algorithm could efficiently use
additional computational resources to decrease the execution time.
We studied strong scaling for two network sizes (2 million and 33 million vessels). Results
revealed that strong scalability of the algorithm increased with problem size (Figure 6.9b).
This can be attributed to the smaller fraction of time spent on I/O as the number of vessels
per block increases. The data also shows that the speedup factors were supra-linear for
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Figure 6.8. Plots of the three scaling functions along with the fitting data (a-c) and the
predicted and observed execution times for the validation trials (d).
portions of the scalability curve. This is caused by the reduction in the number of interactions
between proton tracks and the vessel block as the number of compute nodes increased. The
downturn in scalability is due to a tradeoﬀ between I/O time and the number of floating point
operations required for each vessel block. This is indicative of an algorithm that efficiently
uses its computational resources and is limited by the mathematical and logical operations
and not by memory movement in the computer system.
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Figure 6.9. Plots of the weak scaling (a) and strong scaling (b) of the Dose Calculation
application. Panel (a) plots the wall-clock time T in minutes versus the number of compute
nodes. Panel (b) plots the speedup (S) verses the number of compute nodes (Nc ). The solid
line in Panel (b) represents linear scalability.
6.3.1.3. Memory usage
We quantified the memory usage for five trials (Table 6.6). The peak memory usage was
13.8 GB for the case of the largest vascular network tested which is significantly less than the
64 GB available on the compute nodes. This peak occurred during the initialization of the
dose data structures in the vessel data file. For the Dose Calculation application, the peak
memory usage was 6 GB for the largest vessel block. This low memory utilization can be
attributed to the use of vessel blocks and particle blocks, which reduced the requirements of
memory for every compute node (Section 6.2.2.3). It also suggests that the algorithm could
be ported to GPU architectures for faster parallel computations. The average memory usage
for all three applications was less than 5 GB, suggesting that the long computation times
were caused by the arithmetic and logical operations and not memory movement between
system memory and the processor cache.
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Table 6.6. Memory profiling measurements for Dose Calculation
algorithms.
Memory usage (GB)
DoseInitializationa DoseCalculationb
Trail No. Mean
Peak
Mean
Peak
1
0.50
2.25
0.15
0.28
2
0.32
2.32
0.20
1.87
3
4.45
4.64
2.23
5.95
4
3.04
5.13
1.28
3.10
5
3.76
13.76
1.23
3.20
a:

b:

DoseMergea
Mean Peak
0.80 1.19
0.62 1.28
4.40 5.22
3.00 3.33
2.77 3.33

Memory usage per compute node
Memory usage per vessel block

6.3.2. Simulation of Radiogenic Changes of Blood Flow in an Entire Organ
We measured the computation time for the complete workflow of algorithms (Figure 6.7)
for 3 diﬀerent network sizes (Table 6.4). Qualitatively, the results of the computations may be
visualized in Figure 6.10, which plots the dose, change in vessel radius, and change in bloodflow rate. The dose was deposited in a highly stochastic pattern in the vascular network
(Figure 6.10a). The highest observed dose was cause by a proton track directly crossing
through a blood vessel. This stochastic dose deposition led to highly variable changes in
the vessel radii, from complete closure to a 5% increase in the radius (Figure 6.10b). The
changes in vessel radii resulted in changes in blood flow both inside and outside the radiation
field (Figure 6.10c). In particular, the high doses received in some segments of a few vessel
led to large changes in blood flow throughout the vascular network. This highlights the need
to account for radiation damage at the microscopic level.
Table 6.7 lists the execution times for the mouse and human brain trials. It required
68.6 wall-clock hours to simulate the changes in blood flow from 1 billion protons (E0 = 140
MeV) impinging on a mouse brain. The the trials of human brain networks executed in
49 hours for 4 billion vessels, or 88 hours for 8.5 billion vessels when simulating 2,000,000
protons (E0 = 180 MeV). The execution time was predominated by the dose calculations in
all three trials (98% of the execution time).
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Figure 6.10. The qualitative results of the simulated dose distribution (a), the change in
vessel radii (b), and the relative change in blood flow (c). The dose (a) and the dose
response function (Figure 6.6) result in the changes in vessel radii (b). At doses less than
500 cGy and in vessels larger than 10 micrometers in radius, there is a slight increase in the
vessel radius. The changes in vessel radii results in the blood flow patterns observed in (c).
We compared the observed execution time of the workflow with the predicted time for
using our model of execution time for the dose calculations (see Section 6.2.4.2). The predicted Dose Calculation time over estimated the observed workflow time by 43% to 120%.
We expected the times to be comparable, as the dose calculations predominated the execution time of the workflow. This suggests that the timing model can be used as a conservative
estimate of the run time for the workflow and not just the dose calculations. This provides
a useful tool when designing computational experiments and determining the amount of
computational resources required.

105

Table 6.7. Measured and predicted executions times for workflow trials (Table 6.4).
Trial
1
2
3

Predicted Dose Calculation
Measured Workflow
Time (core-h)
Time (core-h) Time (wall-h)
384,322
175,616
68.6
180,897
126,720
49.4
344,845
223,328
87.2

Tp −Tm
Tm

× 100

118%
43%
54%

6.4. Discussion
We developed a recursive algorithm to calculate the radiation absorbed dose to blood
vessels and characterized its computational performance. Combining the recursive dose
model with previously published techniques for vascular geometry and blood flow modeling,
we evaluated the utility of the recursive dose calculation algorithm to compute the changes
in blood flow in vasculature of mouse and human brains. The major finding of this work is
computing the radiation dose to whole-organ vascular networks is computationally feasible.
The results of this work also show that it is computationally feasible to simulate the change in
blood flow resulting from radiation injury. Computing the changes of blood flow in a human
brain from 2 million protons required 2 to 4 days on a modest-sized cluster. Additionally,
the dose distributions, changes in vessel radius, and changes in blood-flow rates demonstrate
the eﬀects local damage can have on regional blood flow. Using the model of execution
time developed in this work, we estimate whole-organ dose calculations with up to a billion
protons would require 108 core-hours or 58 days on a 4,000-node cluster.
The implication of this study is that new frontiers in computational research related to
vascular injury and radiation biology appear to be opening. In the field of radiation therapy,
this model could eventually find applications in routine treatment planning. Contemporary
treatment planning methods calculate the dose to voxels, which are typically considered to
be independent functional sub-units. Studying the dose to the vascular network enables
consideration of connections in the tissue. For example, it could provide useful insights to
necrosis [11], fibrosis [5], and cardiac toxicity [191], which are all linked to vascular damage.
Additionally, this algorithm could enable the investigation of the implications of vascular
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damage using statistical methods. The large number of blood vessels in a complete organ
may naturally lend themselves to statistical measures. The workflow used in this study
could be applied to the study of vascular injury from any cause. This was demonstrated
for radiation in this work but the modular design of the workflow enables the use of other
models of damage, such as blunt-force trauma [206] or surgical procedures. Additionally,
the workflow could be extended beyond the blood-flow calculations to study diseases, such
as Alzheimer’s or Traumatic Brain Injury [72], both of which are dependent upon vascular
function. That said, it must be understood that the present work demonstrated only the
computational feasibility; the road to practical applications will be long and difficult.
The computational characterization of the dose calculation algorithm in this work are
comparable to those of previous studies. Using Monte Carlo techniques, researchers have
modeled the track-by-track dose deposition in voxelized tissues with a high degree of accuracy
[30, 207, 208]. The use of parallel computing in these algorithms has made whole body
calculations of dose achievable [32] and allowed for the routine clinical use of these algorithms
[207, 208]. It is difficult to compare our work to these studies because of the drastic diﬀerences
in anatomical geometry and proton transport used in this work. For example, Vadapalli et
al. [30] calculated the dose from 25 million protons into a voxelized phantom with 2400 effective dose points in approximately 812 core-hours. Our model calculated the dose from 25
million protons to a 30-vessel network (2400 dose points) in 168 core-hours while simulating
25 million protons through 8.5 billion vessels using our model takes 800 million core-hours.
This can be explained by the competing factors of a simplified proton transport model used
in the dose calculations of our simulation and a more complex (vascular) geometry.
The major strengths of this work were the emphasis on the computational aspects of
the simulations and the modular design of the workflow. This enabled the algorithms to
be separated by function and it simplified the implementation. Additionally, it provides
the opportunity for future extension. For example, simultaneous improvements to the dose
and radiobioloigcal models could be developed in tandem by experts in the respective fields.
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Another strength was the use of simplified models for vascular geometry and particle transport. In addition to enabling the algorithm to complete computations containing billions of
individual vessels and particles, this approach enabled us to quantify the minimum computational requirements of the dose algorithm and workflow.
Our study had three major limitations. First, the calculations of the absorbed dose and
blood flow rate were not validated using new experimental data. This is not a serious limitation because the purpose of this study was to explore questions surrounding computational
feasibility using simple models, and not the ultimate degree of detail and accuracy that is
achievable. Furthermore, the amorphous track structure model used in this work has been
validated previously [35]. The blood flow calculations were validated against a commerciallyavailable computational fluid dynamics package [209]. Future work will be needed to address
the simple algorithms used in this study. For example, the radiation transport algorithm
ignored lateral scatter, energy straggling, and nuclear interactions. This was one of the
simplifications necessary to reduce the computation time of the dose calculations, enabling
the study of dose distribution in whole-organ vascular networks. Another example is the
biological model, which used a simplified damage model that only looked at a fixed end
point. These limitations are the focus on ongoing work in our group. Finally, this study
only used convetional CPUs for the computations. The parallel nature of the Dose Calculation application and its scalability suggest that it might benefit from the use of accelerators,
e.g., GPUs. This could be addressed in future implementations of the algorithm.
This study demonstrated, for the first time, that it is feasible to simulate the changes in
blood flow through the whole-brain caused by vascular injury from localized irradiation. This
new capability could eventually lead to models that improve the prediction and treatment
of radiation-induced necrosis and other deleterious radiation damage.
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7. Conclusion
In this work, we developed and tested algorithms to simulate the changes in blood flow
due to vascular injury caused by irradiation in of an organ’s vasculature. The algorithms
included the capabilities to construct vascular geometries (Chapter 2), calculate the radiation
absorbed dose (Chapter 6), and determine the blood flow rates through individual vessels
(Chapter 3 & 4). The major finding of this work was that it is computationally feasible to
simulate the eﬀects of radiation on blood flow in a whole-organ vasculature. The algorithms
required 89.5 hours to simulate 2 million protons incident on an 8.5 billion vessel network
using 128 compute nodes. Importantly, these studies revealed the dose calculations were
the most time consuming task. The vessel geometry algorithm and blood flow calculation
algorithm both demonstrated the ability to reach 17 billion vessels, i.e. approximately the
number in the human body [58].
This work has the potential open new lines of inquiry on a wide range of related topics
including radiation late eﬀects, circulating tumor cells, and the tumor microenvironment.
For the first time, we are able to consider the cumulative impact of vascular injury to
capillary beds on an organ’s blood flow. This could lead to improvements in modeling drug
distributions, which are dependent on blood flow for delivery. For example, chemotherapy
is often given in conjunction with radiation therapy. The eﬀects of chemotherapy assume
that the vascular network is intact and the drug is able to make it to the tumor. However,
radiation is damaging the vasculature during treatment, and may cause the drug to be
redirected to a healthy region of the organ. The work presented here is a major step toward
understanding the impact and extent of this eﬀect on cancer treatment. This work could also
be used to investigate the relationship between radiation injury of the vasculature, tumor
control, and normal tissue toxicities. The algorithms in this work could be used to generate
hypotheses prior to embarking on experimental research on biological models. With future
improvements, the algorithms could also be used to study diﬀerent types of damage to the
vasculature.
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It is difficult to draw direct comparisons of this work as a whole with the existing literature. However, each component of this work can be directly compared to literature from its
associated field. We built our vascular geometry on existing fractal-based techniques [22–24],
which are less realistic than more advanced techniques [103, 105, 106], but are scalable far
beyond the 360,000 vessels previously achieved [21]. Because goal of this work was to study
the computational aspects of modeling whole-organ vasculature, here it is more important to
model the correct number of vessels than to achieve a highly-accurate geometry. The blood
flow modeling component used in this work is the well-established steady-state approach for
calculations in whole-organ vascular networks [21, 126, 146, 147]. This technique enabled
us to take advantage of improvements in numerical techniques for solving matrices to scale
to billions of vessels [134]. While more advanced fluid dynamics methods exist (i.e. NaiverStokes equations coupled with finite element meshing), their computational expense makes
their implementation at whole-organ scales unfeasible [56, 104, 119]. Our validation of the
blood flow model was coherent with existing literature. We achieved an average accuracy of
5% compared to the 5% diﬀerence observed for 7 diﬀerent models of of aneurysm blood flow
[165]. Our stopping power model was able to fit stopping power and range data with 10%,
which is consistent with previous attempts [174, 175, 184]. Furthermore, it is the only model
available to provide a directly integrable relation to calculate range from stopping power.
The algorithm for determining the dose to the vessels was inspired by the local eﬀects model
(LEM) [35]. LEM determines the biological eﬀect of radiation in normal tissues by calculating the dose to a random set of cells in each dosimetric voxel using radial dose models. Our
model used the same radial dose model, which supports its use in multi-dimensional simulations. Previous work on tumor modeling has studied the eﬀect of radiation on blood flow in
small vascular networks [210–215]. Most of the work has been on characterizing the blood
flow using imaging techniques for determining clinical prognoses. While some computational
modeling on tumor blood flow was done in these studies, none simulated the radiation dose
deposited to the vessels from individual particle tracks, but instead applied a uniform dose
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to all vessels in a volume. Additionally, none provided the ability to model the blood flow
in all of the tissue surrounding the tumor.
The primary strength of this work was the modular design of the workflow. This simplified the implementation of each component by separating the responsibilities among the
applications. Another benefit of this approach is the ability for future modifications of the
algorithms to happen in parallel. For example, the radiation transport algorithm could be
improved to incorporate scattered protons while others improve the blood flow model. In
this way all researchers using the workflow can benefit from improvements made by experts
in each field. A second strength was the use of simple computational methods within each algorithm. This provides an estimate of the minimum performance requirements to simulate a
problem of a given size, more realistic simulations will require more computational resources.
This information is critical to designing future studies for simulating whole-organ or wholeorganism biological processes. Using simplified methods also increases the reproducibility
and transparency of the algorithms.
Future studies are necessary to address the limitations of this work. The primarily limitation is that only the blood flow component was validated in this work. This limitation had
a diminished impact on the current work because until an algorithm was designed and tested
for computational feasibility, it was unknown what level of approximations needed to be validated in the model. Additionally, the blood flow and dose algorithms used well-established
and validated approaches from the literature [21, 35]. The second major limitation was the
simplistic model of vasculature, e.g., vessels as straight tubes and a symmetric branching
ratios. This model was necessary because it is currently the only model demonstrably capable of reaching 9 billion vessels. The simplicity was not a major limitation for the blood
flow calculations because the steady-state model neglected the eﬀects of vessel shape on
blood flow. Finally, to simulate blood flow and dose deposition in multi-billion vessel networks, it was necessary to use many simplifying assumptions, e.g., steady-state blood flow
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and the straight-ahead approximation. This limitation will be overcome in future studies by
developing new algorithms and optimized code to perform the computations.
This work demonstrated that it is feasible to simulate the eﬀects of vascular injury on
whole-organ blood flow with current computational technologies, although simplifications
are necessary. Using the techniques developed in this work, it should now be possible to
synthesize new hypotheses pertaining to vascular damage and sequelae, such as necrosis. In
the future, this may eventually lead to safer treatments and better outcomes for patients.
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